meglumine and Leishmaniasis, Cutaneous

meglumine has been researched along with Leishmaniasis, Cutaneous in 348 studies

Research

Studies (348)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (0.86)	18.7374
1990's	49 (14.08)	18.2507
2000's	138 (39.66)	29.6817
2010's	142 (40.80)	24.3611
2020's	16 (4.60)	2.80

Authors

Authors	Studies
Arif, M; Badshah, M; Hasan, F; Khan, S; Rehman, AU; Shah, AA	1
Clevenbergh, P; Mervillie, K; Mostmans, Y; Richert, B; Van Gysel, J; Vanden Nest, H	1
Alvarez, F; Arana, B; Boni, M; Echevarria, J; Jiménez, A; Llanos-Cuentas, A; López, L; Méndez, C; Quintero, J; Ramos, AP; Rode, J; Tabares, Y; Valencia, B; Vélez, I	1
Alahdin, S; Almani, PGN; Babaei, Z; Bamorovat, M; Keyhani, A; Mohseni, F; Mostafavi, M; Nave, HH; Oliaee, RT; Salarkia, E; Sarlak, M; Sharifi, F; Sharifi, I; Tavakoly, R	1
Aflatoonian, MR; Bahrami, M; Eskandari, SE; Fekri, A; Firooz, A; Ghoorchi, M; Javadi, A; Khamesipour, A; Khatami, A; Sharifi, I	1
Aounallah, A; Belajouza, C; Denguezli, M; Lahouel, M; Manaa, L; Mkhinini, H; Salah, NB	1
Afshari, F; Eskandari, S; Firooz, A; Jaafari, M; Javadi, A; Khamesipour, A; Mohammadi, A; Mortazavi, H; Tasbihi, M	1
Bacellar, O; Carvalho, EM; Fraga, D; Guimarães, LH; Lago, E; Lago, J; Lago, T; Silva, YJ; Werneck, GL	1
Carvalho, AG; Carvalho, CDP; Carvalho, RDP; Dias, JVL; Luz, JGG; Pires, HHR	1
Darchini-Maragheh, E; Derakhshan, Z; Mashayekhi Goyonlo, V	1
Amato, VS; Cota, G; França, AO; Francesconi, F; Hueb, M; Lyra, MR; Oliveira, LFA; Oliveira, RVC; Pimentel, MIF; Pompilio, MA; Rodrigues, BC; Sampaio, RNR; Schubach, AO; Silva, RE; Souza, RM; Valete, CM	1
Alves, J; Barreiros, H; Bonito, F; Costin, A	1
Bartoloni, A; Bartolozzi, D; Corsi, P; Di Muccio, T; Gramiccia, M; Spinicci, M; Trotta, M; Zammarchi, L	1
Abbasi Shaye, Z; Ghanizadeh, S; Layegh, P; Salehi, M; Zabolinejad, N	1
Barroso, DH; Ferreira, MF; Gomes, CM; Martins, SS; Motta, JOCD; Paula, CDR; Porto, C; Rodrigues, BC; Sampaio, RNR	1
Braz, LMA; Celeste, BJ; Goto, H; Lindoso, JAL; Oyafuso, LKM; Ramos-Sanchez, EM; Reis, LC; Yamashiro-Kanashiro, EH	1
Castro, MDM; Cossio, A; Osorio, L; Velasco, C	1
Bartlett, AH; Berger, BA; Castro, MDM; Cossio, A; Pho, MT; Prada, S; Saravia, NG	1
Ayatollahi, J; Bafghi, AF; Shahcheraghi, SH	1
Godarzi, H; Heiran, A; Saki, N	1
Antônio, LF; Bedoya-Pacheco, SJ; Fagundes, A; Lyra, MR; Madeira, MF; Marzochi, MCA; Mouta-Confort, E; Passos, SRL; Pimentel, MIF; Ribeiro, MN; Saheki, MN; Salgueiro, MM; Santos, GPLD; Schubach, AO; Valete-Rosalino, CM; Vasconcellos, ÉCFE	1
Kazuma, FJ; Membrive, NA; Reinhold-Castro, KR; Silveira, TGV; Teixeira, JJV; Teodoro, U	1
Anversa, L; Batista, LR; Cuba, MB; Dias da Silva, VJ; Martins, TY; Nogueira Nascentes, GA; Ramirez, LE; Richini Pereira, VB; Ruiz, LDS; Salles Tiburcio, MG	1
García, M; Monzote, L; Satyal, P; Scull, R; Setzer, WN	1
Brito, NC; Cota, GF; Rabello, A	1
da Silva Pacheco, R; de Fatima Madeira, M; de Oliveira Schubach, A; Fernandes Pimentel, MI; Gagini, T; Maria Valete-Rosalino, C	1
Calvopiña, M; Cevallos, W; Flores, J; Loor, R; Padilla, J; Paredes, Y; Puebla, E	1
Antônio, LF; Brahim, LR; Costa, ADD; Dias, CMG; Duque, MCO; Lyra, MR; Marzochi, MCA; Paes, LEC; Pimentel, MIF; Schubach, AO; Valete-Rosalino, CM; Vieira, IF	1
Cedeño, DL; Fernandez, M; Jones, MA; Murillo, J; Ocampo-Cardona, R; Ríos-Vásquez, LA; Robledo, SM; Velez, ID	1
Carvalho, JP; Cota, E; Cota, G; Moreira, HSA; Rabello, A; Ramalho, DB; Senna, MCR; Silva, RED	1
Bruno, O; Denis, S; Ihcene, KD; Khatima, AO; Naouel, E; Razika, B; Sofiane, B; Zoubir, H	1
Aydın Teke, T; Gayretli Aydın, ZG; Kaman, A; Metin, Ö; Mungan, M; Öz, FN; Tanır, G	1
Cardona-Arias, JA; López-Carvajal, L; Tamayo-Plata, MP; Vélez, ID	1
Abbas, D; Masoud, D; Moein, D; Saeed, M	1
Bordignon, J; Conchon Costa, I; Costa, IN; da Silva, SS; Fanti, JR; Felipe, I; Mizokami, SS; Pavanelli, WR; Verri, WA	1
Çavuş, İ; Ertabaklar, H; Kaya, T; Özbilgin, A; Yıldırım, A	1
Avelar, DM; Cota, G; Moreira, HSA; Pedras, MJ; Rabello, A; Ramalho, DB; Saraiva, L; Senna, MCR; Silva, RED	1
Cupolillo, E; Dávila, AM; Ribeiro-Alves, M; Romero, GA; Torres, DC	1
Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B	1
Behnaz, F; Golshan, Z; Mohammadzadeh, M	1
Emami, S; Momeni, A; Navaei, A; Rafienia, M; Rasoolian, M	1
Dowlati, Y; Firooz, A; Khamesipour, A; Khatami, A; Mehryan, P; Rahshenas, M; Talaee, R; Tehrani, S	1
Blum, JA; Hatz, C; Mosimann, V; Neumayr, A	1
Amorim, FM; Barbosa-Filho, JM; Caldas, JP; Leite, JA; Néris, PL; Oliveira, MR; Rodrigues, LC; Rodrigues, YK; Rodrigues-Mascarenhas, S	1
Calvopiña, M; Hashiguchi, Y; Martinez, L	1
Díaz-Antolín, MP; Nadal-Lladó, C; Nadal-Nadal, A; Terrasa-Sagristà, F	1
Botella Estrada, R; Escutia Muñoz, B; Torres Garcia, Y	1
Lenvers, P; Marty, P; Peyron, F	1
Barnadas, MA; Català, A; Muñoz, C; Puig, L	1
Borges-Costa, J; Campino, L; Filipe, P; Lopes, L; Soares-Almeida, L; Vasconcelos, P	1
Jazayeri, SB; Shahlaee, A	1
Arboleda, M; Díaz, A; Jaramillo, L; Ortiz, D	1
Ghazizadeh, F; Jaafari, MR; Jabini, R; Karimi, G; Khamesipour, A; Vahdati Hasani, F	1
Aoun, K; Bouratbine, A	1
Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN	1
Abbasi, A; Bavarsad, N; Fallah, M; Feizi, E; Jaafari, MR; Kalat, SA; Khamesipour, A; Khashayarmanesh, Z; Neghabi, K	1
Khamesipour, A; Khatami, A; Mortazavi, H; Soori, T; Vasheghani-Farahani, A	1
Attarwala, S; Saleem, M; Talat, H	1
Aoun, K; Benikhlef, R; Bouratbine, A; Faraut, F; Harrat, Z; Jeddi, F; Marty, P; Mary, C; Piarroux, R; Pomares, C; Pratlong, F	1
Barrio, A; Basombrío, MA; Cardozo, RM; Cimino, RO; de Raspi, EM; García Bustos, MF; Parada, LA; Parodi, C; Prieto, GG; Soto, J; Uncos, DA; Yeo, M	1
Fernández-Crehuet, P; Ruiz-Villaverde, R	1
Berry, A; Charafeddine, K; Ghosn, N; Habib, RH; Issa, G; Khalifeh, H; Khalifeh, I; Rady, A; Saroufim, M	1
Kutlubay, Z; Polat, E	1
Baba, N; Boui, M; Frikh, R; Hjira, N; Lamsyah, H; Marcil, T; Oumakhir, S	1
Alsina Gibert, M; Estrach, T; Fuertes, I; Giavedoni, P; Iranzo, P	1
Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M	1
El Benaye, J; El Haouri, M; Miloudi, M	1
Bertho, ÁL; Cunha, CF; Da-Cruz, AM; Ferraz, R; Gomes-Silva, A; Lyra, MR; Mendonça, SC; Pimentel, MI; Schubach, AO; Valete-Rosalino, CM	1
Awan, MM; Jamal, Q; Khan, NH; Shah, A; Sutherland, C; Wahid, S	1
Aksoy, M; Özbilgin, A; Sürücü, HA; Turan, E; Yeşilova, Y	1
Cardona-Arias, JA; López-Carvajal, L; Vélez, ID	1
Barati, DA; Bojd, MS; Hemmati, M; Karamian, M; Salehabadi, A	1
Aydın Teke, T; Bayhan, Gİ; Gayretli Aydın, ZG; Metin Timur, Ö; Mungan, M; Öz, N; Tanır, G; Yılmaz, N	1
Aksoy, M; Ardic, N; Oghumu, S; Satoskar, AR; Surucu, HA; Yesilova, A; Yesilova, Y	1
Ishkhanian, S; Shanehsaz, SM	1
de Barros, NB; de Figueiredo Nicolete, LD; Ferreira, Ados S; Macedo, SR; Nicolete, R	1
Ahmadi, F; Bahrami, S; Esmaeilzadeh, S; Zarei, M	1
Aguiar, MG; de Morais-Teixeira, E; Ferreira, LA; Rabello, A; Soares de Souza Lima, B	1
El kartouti, A; Elbenaye, J; Miloudi, M	1
Aksakal, M; Serarslan, G	1
Afzal Aghaee, M; Khademi, Z; Layegh, P; Moghiman, T	1
Araújo, EJ; Conchon-Costa, I; da Silva, SS; Fanti, JR; Felipe, I; Kawakami, NY; Miranda, MM; Mizokami, SS; Panis, C; Pavanelli, WR; Sforcin, JM; Teixeira, FH; Verri, WA; Watanabe, MA	1
Khamesipour, A; Mohammadi, AM; Nateghi Rostami, M; Seyyedan Jasbi, E	1
Ezatpour, B; Kheirandish, F; Mahmoudvand, H; Rashidipour, M; Saedi Dezaki, E; Sharifi, I	1
Abbas, O; Alam, E; Khalifeh, I; Moukarbel, R	1
Bertho, AL; Cunha, CF; Da-Cruz, AM; Ferraz, R; Lyra, MR; Pimentel, MI; Schubach, AO	1
Aït-Oudhia, K; Benbetka, S; Benikhlef, R; Eddaikra, N; Harrat, Z; Kherachi Djenad, I; Moulti-Mati, F; Oury, B; Sereno, D	1
Aristides, SM; Fernandes, AC; Lonardoni, MV; Pedroso, RB; Silveira, TG; Venazzi, EA; Zanzarini, PD	1
Hashemzadeh, S; Khoddami, M; Layegh, P; Rajabi, O	1
Azorin, D; Noguera-Morel, L; Xirotagaros, G	1
Aristides, SM; de Mello, TF; Demarchi, IG; Donatti, L; Fernandes, AC; Lonardoni, MV; Pedroso, RB; Silveira, TG; Venazzi, EA	1
Brasileiro, A; García-Martinez, P; Giménez-Arnau, AM; Martín-Ezquerra, G; Pujol, RM	1
Bedoya, A; Cruz-Barrera, ML; Daza, CD; Echeverry, MC; Lopez, MC; Mariño, ML; Perez-Franco, JE; Robayo, ML; Saavedra, CH	1
Andrade, MS; Corrêa-Júnior, JD; Demicheli, C; Fernandes, FR; Ferreira, LA; Frézard, F; Lanza, JS; Magalhães-Paniago, R; Melo, MN; Vilela, JM	1
Hajaliloo, E; Hajjaran, H; Kazemi-Rad, E; Khadem-Erfan, MB; Mohebali, M; Oshaghi, MA; Raoofian, R; Reisi Nafchi, H	1
Akhdari, N; Amal, S; Hocar, O; Ouadi, Z; Tassi, N	1
Cota, G; Rabello, A; Senna, MC; Silva, RE; Toledo, A	1
Arias-Santiago, S; Blasco-Morente, G; Martínez-López, A; Pérez-López, I	1
Corpas-López, V; Díaz-Sáez, V; Gijón-Robles, P; López-Viota, J; López-Viota, M; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Mancilla, MJ; Morillas-Márquez, F; Navarro Moll, MC	1
Barud, HS; Borges, VM; Celes, FS; de Oliveira, CI; Khouri, R; Ribeiro, SJ; Trovatti, E; Van Weyenbergh, J	1
Omidian, E; Radmanesh, M	1
Carvalho de Castro, E; de Araújo-Melo, MH; de Oliveira Schubach, A; de Vasconcellos Carvalhaes Oliveira, R; do Nascimento Brahim Paes, LR; Jardim Duarte, CC; Oliveira Bezerra, DC; Oliveira de Barcelos, R; Pereira Bom Braga, F; Ramos Ferreira Terceiro, B; Salgado de Sousa Torraca, T; Valete-Rosalino, CM	1
Handjani, F; Hatam, GR; Mohammadpour, I; Motazedian, MH	1
Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J	1
Marcoval, J; Penín, RM	1
Hussain, I; Janjua, SA; Munir, A	1
Galindo-Sevilla, N; Mancilla-Ramirez, J; Martinez-Rojano, H; Quiñonez-Diaz, L	1
Alborzi, A; Fakhar, M; Hatam, GR; Kadivar, MR; Motazedian, MH; Pouladfar, GR	1
Jaffary, F; Mahzoni, P; Nilforoushzadeh, MA; Sadeghian, G; Shirani-Bidabad, L; Ziaei, H	1
Achour Barchiche, N; Madiou, M	1
Coraspe, V; Delgado, O; Franco-Paredes, C; Navarro, P; Rivas, MA; Rodriguez-Morales, AJ; Silva, S	1
Amaral, VF; Canto-Cavalheiro, MM; Charret, KS; da Silva, EF; Echevarria, A; Leon, LL; Rodrigues, RF	1
Baron, AR; Dueñes, B; Mahecha, Mdel P; Montaña, R; Montero, LM; Reithinger, R; Sanchez, BF; Vega, JC	1
Badri, T; Ben Brahim, M; Ben Jannet, S; Chouk, S; Daghfous, R; El Aïdli, S; Fenniche, S; Marrrak, H; Mlika, BR; Mokhtar, I	1
Sadeghi, M; Sadeghian, G; Ziaei, H	1
Brito, ME; Luna, CF; Medeiros, AC; Pereira, VR; Reis, LC; Silva, CJ; Souza, MA	1
Layegh, P; Moghiman, T; Naviafar, P; Pezeshkpoor, F; Soruri, AH	1
Ansari, N; Firouz, A; Jaffary, F; Nilforoushan, Z; Nilforoushzadeh, MA; Siadat, AH	1
Mahmoudi, M; Nilforoushzadeh, MA; Saberi, S; Shirani-Bidabadi, L; Siadat, AH; Zolfaghari-Baghbaderani, A	1
Barral, AM; de Almeida, HL; Diehl, ES; Fleury, RN; Ura, S	1
Aitourhoui, M; Belgnaoui, FZ; Bouhllab, J; Elguelbazouri, N; Hassam, B; Marcil, T; Qasmi, S; Senouci, K	1
Akrout, R; Baklouti, S; Fourati, H; Hachicha, I; Hdiji, N; Sellami, M	1
Cheffaï, S; Dhaoui, MR; Doss, N; Hammami, H; Jaber, K; Youssef, S	1
Barnabas, GA; Morrone, A; Padovese, V; Terranova, M; Toma, L	1
Ejaz, A; Ul Bari, A	1
García-Lázaro, M; Natera, C; Rivero, A; Villar, C	1
Bacellar, O; Carvalho, EM; Guimarães, LH; Lago, EL; Machado, PR; Morgan, DJ; Schriefer, A	1
Firdous, R; Ranja, K; Yasinzai, M	1
Feily, A; Namazi, MR; Yaghoobi, R	1
Figueroa, RA; Miranda, MC; Prager, M; Zea, DF	1
Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Teva, A; Vieira, F	1
Dorlo, TP; Kager, PA	1
Dorta, ML; Miguel, DC; Pelli de Oliveira, MA; Pereira, LI; Ribeiro-Dias, F; Uliana, SR; Yokoyama-Yasunaka, JK; Zauli-Nascimento, RC	1
Del Giudice, P; Dereure, J; Hakimi, S; Le Quellec, A; Rivière, S	1
Caldas, ED; Neves, DB; Sampaio, RN	1
Bagherani, N; Maraghi, S; Rafiei, A; Yaghoobi, R	1
Bianciardi, P; Cañavate, C; Cruz, I; Miró, G; Mortarino, M; Oliva, G; Vischer, C	1
Azeredo-Coutinho, RB; Baptista, C; Conceição-Silva, F; de Almeida Marzochi, MC; de Camargo Ferreira E Vasconcellos, E; de Fátima Madeira, M; de Matos Salgueiro, M; de Oliveira Schubach, A; de Souza Coutinho, R; Fernandes Pimentel, MI; Pereira Quintella, L; Roberto Mortari, S; Rosandiski Lyra, M; Soares Moreira, J; Valete-Rosalino, CM	1
Ezzine Sebai, N; Fazaa, B; Kamoun, MR; Khaled, A; Kharfi, M; Mrabet, N; Zeglaoui, F	1
Baba, M; Bal, N; Durdu, M; Eryilmaz, A; Yiğit, F	1
Adaui, V; Arévalo, J; Cupolillo, E; Dujardin, JC; Ribeiro-Alves, M; Romero, GA; Torres, DC	1
Aflatoonian, MR; Dowlati, Y; Fekri, AR; Khamesipour, A; Mahboudi, F; Modabber, F; Nadim, A; Sharifi, I	1
García, C; García, RG; Kampeerapappun, P; López, M; López-Jaramillo, P; Rincón, MY; Silva, SY; Smith, DJ; Smith, E; Vélez, ID	1
Ben Osman, A; Chaker, E; El Euch, D; Ishak, F; Kort, R; Mokni, M; Zaraa, I	1
Abbas, MM; Masood, S; Mumtaz, MJ; Rashid, BN; Tabassum, S; Ullah Rao, MS	1
Aghaie, H; Heshmatkhah, A; Shamsi Meymandi, S; Zandi, S	1
López, L; Mestra, L; Rodríguez, E; Rojas, C; Sánchez, X; Vélez, I	1
Alves, FP; Ashman, JA; Beckmann, AM; Bogatzki, LY; Campos-Neto, A; Coler, RN; Cowgill, KD; Fernandes, DF; Kahn, SJ; Nascimento, E; Piazza, FM; Pine, SO; Reed, SG; Vieira, EP	1
Guerra-Giraldez, C; Mortara, RA; Price, HP; Ramos, CS; Smith, DF; Uliana, SR; Yokoyama-Yasunaka, JK	1
Nilforoushzadeh, MA; Sadeghian, G; Shirani-Bidabadi, L; Ziaei, H	1
Arasteh, M; Babakoohi, S; Firooz, A; Kashani, MN; Nilforoushzadeh, MA; Sadr, B	1
Craft, N; Da-Cruz, AM; de Oliveira, MP; de Oliveira-Neto, MP; Maretti-Mira, AC; Pirmez, C	1
Achour, I; Chakroun, A; Charfeddine, I; Ghorbel, A; Hammami, B; Mnejja, M; Turki, H	1
Layegh, P; Rahsepar, AA; Rahsepar, S	1
Alcântara, L; Carvalho, EM; Glesby, MJ; Guimarães, LH; Machado, PR; Morgan, DJ; Newlove, T	1
Motta, JO; Sampaio, RN	1
Ayadi, N; Béji, M; Bouomrani, S; Farah, A	1
Habibi, S; Handjani, F; Hatam, GH; Motazedian, MH; Pourmohammadi, B; Sarkari, B	1
Dabiri, S; Javadi, A; Nadji, M; Shamsi Meymandi, M; Shamsi Meymandi, S	1
Delgado, G; Granados, D; Mariño, A; Plaza, D; Sánchez, Y	1
Costa, MA; da Veiga-Júnior, VF; de Souza Lima, MM; Dias-Filho, BP; dos Santos, AO; Nakamura, CV; Ueda-Nakamura, T	1
Cuzzi, T; de Camargo Ferreira e Vasconcellos, E; de Fátima Madeira, M; de Matos Salgueiro, M; de Oliveira Schubach, A; Lambert Passos, SR; Mouta-Confort, E; Quintella, LP; Valete-Rosalino, CM	1
Barati, M; Fasihi Harandi, M; Hakimi Parizi, M; Khamesipour, A; Nakhaee, N; Nosratabadi, J; Sharifi, I; Shokri, A	1
Amaral, V; Campos, MC; Canto-Cavalheiro, MM; Charret, KS; Dos Reis, C; Echevarria, A; Leon, LL; Rodrigues, RF	1
Harms, G; Reiter-Owona, I; Richter, J; Scherbaum, H; Stich, A	1
Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Vieira, FA	1
de Souza, W; Godinho, JL; Rodrigues, JC; Silva, R; Simas-Rodrigues, C; Ürmenyi, TP	1
Garcerant, D; Gore Saravia, N; Miranda, MC; Montero, LM; Muvdi Arenas, S; Nicholls, RS; Osorio, L; Pérez, M; Prager, M; Rodríguez-Barraquer, I; Rojas, MX; Rubiano, LC	1
Alvi, RU; Masood, S; Naveed, S	1
Abebe, Z; Dassoni, F; Morrone, A; Naafs, B	1
Case, AJ; Davis, GD; Hamid, H; Nadir, M; Robert, LL; Safi, N	1
Benjelloun, S; El Haouri, M; El Kartouti, A; Er-Rami, M; Jakar, A; Khalloufi, A; Lahlou, H; Zeroual, A	1
Carrillo, LM; López, L; Robledo, SM; Rodríguez, E; Vélez, ID	1
Assareh, A; Azarian, B; Hadighi, R; Hajjaran, H; Mohebali, M; Vaziri, B	1
López, L; Robayo, M; Vargas, M; Vélez, ID	1
Andrade, LC; Daher, EF; Junior, GB; Libório, AB; Lima, CG; Martins, AM; Mota, RM; Oliveira, RA; Sanches, TR; Seguro, AC	1
Azeredo-Coutinho, RB; Baptista, C; de Oliveira, Rde V; Madeira, Mde F; Moreira, JS; Pimentel, MI; Salgueiro, Mde M; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM; Vasconcellos, Ede C	1
de Saldanha, RR; Martins-Papa, MC; Muniz-Junqueira, MI; Sampaio, RN	1
Esfandiarpour, I; Farajzadeh, S; Fathabadi, EA; Heshmatkhah, A; Rahnama, Z	1
Aguado-Lobo, M; Borbujo, J; Espinosa-Lara, P; García-Donoso, C; Martínez-Sánchez, D; Moreno-Torres, A; Romero-Maté, A; Tardío, JC	1
Aguado, M; Borbujo, J; Córdoba, S; Gandolfo Cano, M; Huerta-Brogera, M; Martínez-Morán, C; Romero, A	1
Dastgheib, L; Mirashe, Z; Naseri, M	1
Duffey, GB; Horton, LE; Paniz Mondolfi, AE; Perez-Alvarez, A; Reyes Jaimes, O; Tirado, M; Zerpa, O	1
Brelaz-de-Castro, MC; da Rocha, LF; de Almeida, AF; de Assis-Souza, M; de Oliveira, AP; Pereira, VR	1
Molinet, FJ; Noronha, EF; Romero, GA	1
Alchorne, MM; Macedo, FS; Ogawa, MM; Tomimori-Yamashita, J	1
Aminjavaheri, M; Momeni, AZ; Reiszadae, MR	1
Alavi, A; Esfandiarpour, I	1
Handjani, F; Nouhpisheh, MK; Salmanpour, R	1
Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M	1
Abolhassani, M; Alimohammadian, MH; Darabi, H; Kariminia, A	1
Belhadj, S; Chaker, E; Dedet, JP; Hammami, M; Kallel, K; Pratlong, F	1
Faghihi, G; Tavakoli-kia, R	1
Gianotti, R; Rigoni, C; Veraldi, S	1
Badaró, R; Bittencourt, A; Follador, I; Nunes, VL; Silva, N; Straatmann, A	1
Báfica, A; Barral, A; Freitas, LA; Nascimento, EG; Oliveira, F	1
Bogenrieder, T; Landthaler, M; Lehn, N; Stolz, W	1
Flores M, RM; Macêdo, Vde O; Noronha, EF; Romero, GA	1
Enk, CD; Gardlo, K; Hochberg, M; Ingber, A; Ruzicka, T	1
Bhutto, AM; Hashiguchi, Y; Nonaka, S; Soomro, RA	1
Cordova, X; Sorci, JJ; Usatine, RP	1
Barão, SC; Giorgio, S	1
Amini Harandi, A; Asilian, A; Faghihi, G; Momeni, A; Sadeghinia, A	1
FLOCH, H	1
Bari, I; Ejaz, A; Iftikhar, N	1
Darie, H; Debord, T; Gros, P; Imbert, P; Rapp, C; Roué, R; Simon, F	1
da Silva, JB; de Melo, AL; Demicheli, C; Falcão, CA; Frézard, F; Ochoa, R; Rossi-Bergmann, B; Sinisterra, RD	1
ESCHER, D; LAHAM, E	1
CORNEJO, A	1
Cardenas, GA; Cohen, C; Gonzalez-Serva, A	1
Isaac-Márquez, AP; Lezama-Dávila, CM	1
Lamothe, J	1
Asilian, A; Faghihi, G; Momeni, A; Sadeghinia, A	1
Armijos, RX; Calvopiña, M; Mancheno, M; Rodriguez, R; Weigel, MM	1
Asilian, A; Iraji, F; Momeni, AZ; Shahtalebi, MA; Vali, A	1
Allahverdiyev, AM; Culha, G; Durdu, M; Memisoglu, HR; Uzun, S	1
Querido, J	1
Asilian, A; Enshaeieh, Sh; Faghihi, G; Shariati, F; Sharif, A; Siadat, AH	1
de Carvalho, EM; de Farias Guerra, MV; de la Glória Orge Orge, M; de Oliveira Macêdo, V; Paes, MG; Romero, GA	1
Cardoso, JE; de Oliveira-Silva, F; Fernandes, AP; Ferreira, LA; Gonçalves, GS; Maciel, FC; Rabello, A; Souza, RC	1
Gómez, A; Henao, HH; Osorio, Y; Saravia, NG; Travi, B	1
Bouassida, S; Boudaya, S; Maalej, N; Masmoudi, A; Mseddi, M; Souissi, A; Turki, H; Zahaf, A	1
Andersen, EM; Berman, JD; Colina, O; Cruz-Saldarriaga, M; Echevarria, J; Llanos-Cuentas, A; Luz-Cjuno, M; Miranda-Verastegui, C	1
Barral, A; Boaventura, V; Campos, LF; Costa, JM; da Cruz Junior, AC; da Rocha, AV; de Oliveira, CI; Noronha, A; Novais, FO; Oliveira, JG	1
Serarslan, G; Söğüt, S; Yilmaz, HR	1
Cruz, I; Flores, MD; López-Vélez, R; Mateo, M	1
Berman, J; Soto, J; Toledo, J; Vega, J	1
Arévalo, I; Llanos-Cuentas, A; Matlashewski, G; Miranda-Verástegui, C; Ward, BJ	1
Guarneri, C; Guarneri, F	1
Badaro, R; Correia, TM; David, JR; de Freitas, LA; Lobo, IM; Nakatani, M; Netto, E; Oliveira, MI; Soares, MB	1
Moosavi, Z; Nakhli, A; Rassaii, S	1
Bouassida, S; Kitar, A; Masmoudi, A; Rebai, M; Turki, H; Zahaf, A	1
Cavalli, R; Cremonesi, R; Galloni, C; Veraldi, S	1
Atabek, ME; Pirgon, O; Unal, E	1
Aşçioglu, O; Canoz, O; Doganay, M; Ferahbaş, A; Mistik, S; Utaş, S; Yaman, O	1
Boudaya, S; Maalej, N; Masmoudi, A; Turki, H; Zahaf, A	1
Boucher, P; Hadighi, R; Hajjaran, H; Khamesipour, A; Mohebali, M; Ouellette, M	1
Ouellette, M; Rojas, R; Saravia, NG; Valderrama, L; Valderrama, M; Varona, MX	1
Butt, UA; Manzur, A	1
Boumis, E; Chinello, P; Della Rocca, C; Paglia, MG; Petrosillo, N; Proietti, MF	1
Katsambas, A; Kontochristopoulos, G; Papakonstantinou, AM; Petropoulou, H; Stavropoulos, PG	1
Nilforoushzadeh, MA; Sadeghian, G	1
Buffet, PA; Darie, H; Freitag, S; Gounod, N; Le Guern, AS; Therby, A; Van Der Vliet, D	1
Ansari, N; Jaffray, F; Nilfrousihzadeh, MA; Reiszadeh, MR	1
Abtahi, N; Razmavar, MR; Salmanpour, R	1
Bermúdez, H; Boelaert, M; Chappuis, F; Desjeux, P; Dujardin, JC; Garcia, L; Rojas, E	1
Grimaldi, GJ; Oliveira-Neto, MP; Porrozzi, R; Teva, A	1
Costa, M; Ferrer, L; Martorell, S; Miranda, S; Ramis, A	1
Shajari, G; Taghaviardakani, A; Talaei, R; Talari, SA; Vakili, Z	1
Dowlati, Y; Eskandari, SE; Firooz, A; Ghoorchi, MH; Gorouhi, F; Hooshmand, B; Khamesipour, A; Khatami, A; Nassiri-Kashani, M; Rashighi-Firoozabadi, M	1
Cruz, A; Herwaldt, BL; Palacios, R; Rainey, PM; Saravia, NG; Stagni, G; Trujillo, R	1
Cadena, H; Tabares, CJ; Travi, BL	1
Mumtaz, N; Rahman, SB; ul Bari, A	1
Iraji, F; Nilfroushzadeh, MA; Sadeghian, G	1
Barroso, PA; Calvopina, M; Hashiguchi, Y; Kato, H; Korenaga, M; Marco, JD	1
Derakhshan, R; Haftbaradaran, E; Jaffary, F; Moradi, S; Nilforoushzadeh, MA	1
Adaui, V; Arevalo, J; Chappuis, F; De Doncker, S; Dujardin, JC; Lazo, M; Llanos-Cuentas, A; Loayza-Muro, R; Maurer, A; Miranda-Verástegui, C; Ramirez, L; Tulliano, G; Zimic, M	1
Ejaz, A; Iftikhar, N; Raza, N	1
Arevalo, I; Llanos-Cuentas, A; Matlashewski, G; Pollack, H; Quispe, A; Spaeth, G; Tulliano, G	1
Fontes, CJ; Hueb, M; Nery, AF; Rodrigues, AM	1
Frutuoso, MS; Pompeu, MM; Silva, TM; Sólon, FR; Sousa, AQ; Teixeira, MJ	1
Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL	1
Akhoundi, B; Fotouhi, A; Hooshmand, B; Kabir, MJ; Mohebali, M; Nadim, A; Rahnema, A; Razaghian, AR; Zarei, Z	1
Boucher, P; Hadighi, R; Khamesipour, A; Meamar, AR; Mohebali, M; Ouellette, M; Roy, G	1
Dabiri, SH; Esfandiarpour, I; Yousefi, K	1
Layegh, P; Moghiman, T; Pezeshkpoor, F; Shakeri, MT; Vosugh, EM; Yazdanpanah, MJ	1
Azeredo-Coutinho, RB; Callahan, H; Max, G; Mendonça, SC; Portal, AC	1
Dabiri, SH; Esfandiarpour, I	1
Bottini, S; Lunardon, L; Persico, MC; Veraldi, S	1
Akrout, F; Ayadi, N; Bouassida, S; Boudaya, S; Khabir, A; Masmoudi, A; Meziou, TJ; Sallemi, T; Turki, H; Zahaf, A	1
Abraham, D; Cajal, SP; Juarez, M; Krolewiecki, AJ; Matsumoto, T; Mimori, T; Romero, HD; Taranto, NJ	1
Amaral, FM; Aragão-Filho, WC; Costa, GC; Frazão, JB; Guerra, RN; Maciel, MC; Nascimento, FR; Patrício, FJ; Pereira, PV; Pereira, WS; Rebêlo, JM; Ribeiro, MN; Silva, LA; Sousa, SM	1
Amato Neto, V; Amato, VS; Graf, ME; Nicodemo, AC; Siqueira, AM; Tuon, FF	1
Dahdah, MJ; Ghosn, S; Kibbi, AG	1
Balderrama, M; Berman, JD; Rea, J; Soto, J; Soto, P; Toledo, J; Valda, L	1
Akkaya, VB; Basak, PY; Ceyhan, AM; Erturan, I; Yildirim, M	1
Akrout, F; Ayadi, N; Bouassida, S; Boudawara, T; Bouzid, L; Khabir, A; Masmoudi, A; Meziou, TJ; Turki, H; Zahaf, A	1
Elfekih, N; Ezzine, N; Fazaa, B; Hajlaoui, K; Kamoun, MR; Kastalli, S; Loueslati, MH; Zeglaoui, F	1
Buffet, P; Caumes, E; Gentilini, M	1
Berman, J; Grogl, M; Hernandez, N; Mejia, H; Soto, J	1
Hernández, DE; Martínez, C; Oliver, M; Planas, G	1
Aminjavaheri, M; Momeni, AZ	2
Arana, BA; Arana, FE; Berman, JD; Navin, TR; Rosenkaimer, F	1
Belec, L; Bouree, P	1
Aragort de Rossell, R; de Jesús de Durán, R; Rodríguez, AM; Rossell, O	1
Berman, JD; Grogl, M; Soto-Mancipe, J	1
Furtado, T; Nogueira-Castañon, MC; Pereira, CA	1
Barroeta, S; Bonfante-Garrido, R; de Alejos, MA; Grimaldi Júnior, G; Meléndez, E; Momen, H; Torrealba, J; Valdivia, O	1
Ferreira, ME; Fournet, A; Fuentes, S; Hocquemiller, R; Nakayama, H; Rojas De Arias, A; Schinini, A; Torres De Ortiz, S	1
Bertho, AL; Coutinho, SG; Da-Cruz, AM; De Luca, PM; McMahon-Pratt, D; Mendonça, SC; Oliveira, MP; Soong, L	1
Bai, M; Kastanioudakis, I; Kostoula, A; Skevas, A	1
Agudelo, S; Berman, J; Grogl, M; Hendrickx, E; Modabber, F; Puerta, J; Velez, I	1
Bouthelier Moreno, M; de Juan Martín, F; Fortuño Cebamanos, B; Gilaberte Calzada, Y; Justa Roldán, ML; Navarro Serrano, E; Sáez de Adana Pérez, E	1
da Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A	1
Gonçalves-Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A	2
Alvarez, E; Canales, J; Davies, CR; Dye, C; Leon, E; Llanos-Cuentas, EA; Roncal, N; Sharp, SJ	1
Isaza, DM; Mosca, W; Restrepo, M	1
Demar, M; Knobloch, J	1
Berman, J; Fuya, P; Herrera, R; Soto, J	1
Carvalho, EM; D'Oliveira Júnior, A; Machado, PR	1
del Giudice, P; Dellamonica, P; Haas, H; Lacour, JP; Le Fichoux, Y; Marty, P; Perrin, C; Pratlong, F	1
Black, GF; Blackwell, JM; Braga, R; Ishikawa, EA; Kima, P; McMahon-Pratt, D; Quinnell, RJ; Shaw, JJ; Shaw, MA; Silveira, FT; Soong, L	1
Abahussein, A; al-Gindan, Y; Alkhawajah, AM; Jain, S; Larbi, E	1
Aste, N; Biggio, P; Ferreli, C; Pau, M	1
Aktepe, N; Avci, S; Erel, O; Gurel, MS; Kocyigit, A; Seyrek, A; Vural, H	1
López-Ríos Velasco, J; Pérez Cidoncha, P; Pisón Aragón, F; Puente López, G; Rodríguez Sánchez, A	1
Araujo, ML; Conceicao-Silva, F; Coutinho, SG; Cuzzi-Maya, T; Marzochi, KB; Marzochi, MC; Momen, H; Oliveira, AL; Oliveira, AV; Pacheco, RS; Schubach, A	1
Abajo, P; Daudén, E; Martín, R	1
Gilead, L; Horev, L; Jonas, F; Klaus, SN; Zlotogorski, A	1
Fernandes, O; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Souza, CS	1
Alvarez, R; Fortuño, B; García, R; Sánchez, M; Simal, E; Yus, C	1
Robledo, SM; Saravia, NG; Valencia, AZ	1
Andrade, AC; Drummond, JB; Passos, VM; Ribeiro, AL; Volpini, AC	1
Krause, G; Kroeger, A	1
Khalid, M; Mujtaba, G	1
Ardehali, S; Handjani, F; Panjehshahin, MR; Salmanpour, R; Tabatabaee, HR; Tabei, SZ; Zerehsaz, F	1
Greiner, M; Moritz, A; Steuber, S	1
Greiner, M; Moritz, A; Schirrmann, I; Steuber, S	1
Blackwell, JM; Cabrera, M; Castes, M; Convit, J; Shaw, MA; Trujillo, D	1
Andrade-Narvaez, FJ; Canto-Lara, SB; Damian-Centeno, AG; Vargas-Gonzalez, A	1
Barreto, SM; Krettli, AU; Lima e Costa, MF; Passos, VM; Romanha, AJ; Volpini, AC	1
Hepburn, NC	1
Ahmadiani, A; Azar, A; Ebtekar, M; Ghazanfari, T; Hassan, ZM; Naderi, G	1
Banzet, S	1
Afonso, LC; Costa , CA; Genaro, O; Gollob, KJ; Mayrink, W; Oliveira, MA; Pinto, JA; Toledo, VP	1
Añez, N; Cazorla, D; Sánchez de Mirt, A; Yépez, J	1
Develoux, M; Huerre, M; Ndiaye, B; Thierno, DM	1
Angelo, C; Gradoni, L; Grosso, MG; Ludovisi, A; N'Doni, F; Paradisi, M; Puddu, P	1
Dordain, ML; Rapp, C; Simon, F	1
Alvarez, E; Arevalo, I; Llanos-Cuentas, A; Matlashewski, G; Meng, TC; Miller, R; Najar, E; Ward, B	1
Guerra, MV; Macêdo, VO; Paes, MG; Romero, GA	1
Arana, B; Diaz, A; Rizzo, N	1
Armijos, RX; Weigel, MM	1
Añez, N; Gonzalez, N; Guevara, P; Premoli-de-Percoco, G; Ramirez, JL	1
De Souza, AA; Ishikawa, EA; Lainson, R; Silveira, FT	1
da Costa, CA; Genaro, O; Machado-Pinto, J; Marques, MJ; Mayrink, W; Modabber, F; Pinto, J	1
Benjelloune, A; Berraho, A; Charif Chefchaouni, M; El Lyacoubi, M; Lamrani, R	1
Calza, L; Chiodo, F; di Bari, MA; Manfredi, R	1
Barrios, AA; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V	1
Franke, ED; Grogl, M; Thomason, TN	1
Bigaignon, G; Cornu, G; Mattot, M; Ninane, J; Vermylen, C	1
da Costa, CA; Dias, M; Genaro, O; Lima, Ade O; Magalhaes, PA; Mayrink, W; Melo, MN; Michalick, MS; Nascimento, E; Toledo, VP	1
Anastassiadis, G; Asvesti, C; Kolokotronis, A; Zographakis, I	1
Berman, JD; Herwaldt, BL; Neva, FA	1
Marr, JJ; Martinez, S	1

Reviews

12 review(s) available for meglumine and Leishmaniasis, Cutaneous

Article	Year
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PloS one, 2017, Volume: 12, Issue:9 Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cryotherapy; Databases, Factual; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2017
Cutaneous leishmaniasis in North Africa: a review. Parasite (Paris, France), 2014, Volume: 21 Topics: Africa, Northern; Animals; Antiprotozoal Agents; Climate; Disease Outbreaks; Disease Reservoirs; Endemic Diseases; Humans; Incidence; Insect Vectors; Leishmania infantum; Leishmania major; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Rodentia; Virulence; Zoonoses	2014
Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials. PloS one, 2015, Volume: 10, Issue:5 Topics: Confidence Intervals; Controlled Clinical Trials as Topic; Humans; Hyperthermia, Induced; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Models, Biological; Organometallic Compounds; Treatment Outcome	2015
Cutaneous Leishmaniasis of the Eyelids: A Case Series with Molecular Identification and Literature Review. The Korean journal of parasitology, 2016, Volume: 54, Issue:6 Topics: Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Cytological Techniques; Eyelid Diseases; Eyelids; Female; Humans; Infant; Injections, Intramuscular; Iran; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Microbiological Techniques; Microscopy; Organometallic Compounds; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA	2016
Intermediate/borderline disseminated cutaneous leishmaniasis. International journal of dermatology, 2013, Volume: 52, Issue:4 Topics: Antiprotozoal Agents; Child; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2013
[Cutaneous leishmaniasis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:6 Topics: Amphotericin B; Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Controlled Clinical Trials as Topic; Diagnosis, Differential; Double-Blind Method; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Photochemotherapy; Time Factors	2003
Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis. International journal of dermatology, 2008, Volume: 47, Issue:2 Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Developing Countries; Endemic Diseases; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine	2008
[Treatment of localized cutaneous leishmaniasis]. Annales de dermatologie et de venereologie, 1994, Volume: 121, Issue:6-7 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine	1994
Leishmaniasis: report of 33 cases and a review of the literature. Comparative immunology, microbiology and infectious diseases, 1993, Volume: 16, Issue:4 Topics: Allopurinol; Animals; Child, Preschool; Disease Reservoirs; Female; Global Health; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Pentamidine; Protozoan Vaccines	1993
Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Archives of dermatology, 1998, Volume: 134, Issue:2 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Antigens, Protozoan; Antiprotozoal Agents; Blotting, Western; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Injections, Intradermal; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Middle Aged; Paromomycin	1998
Cutaneous leishmaniasis. Clinical and experimental dermatology, 2000, Volume: 25, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Life Cycle Stages; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence; Skin	2000
Chemotherapy of cutaneous leishmaniasis: a review. Medical microbiology and immunology, 2001, Volume: 190, Issue:1-2 Topics: Antifungal Agents; Antimony; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Ointments; Organometallic Compounds; Phosphorylcholine	2001

Trials

71 trial(s) available for meglumine and Leishmaniasis, Cutaneous

Article	Year
A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World. PLoS neglected tropical diseases, 2022, Volume: 16, Issue:3 Topics: Adult; Antiprotozoal Agents; Humans; Hyperthermia, Induced; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Treatment Outcome	2022
Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial. PLoS neglected tropical diseases, 2022, Volume: 16, Issue:7 Topics: Antiprotozoal Agents; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2022
Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2022, Sep-29, Volume: 28, Issue:9 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pilot Projects; Treatment Outcome	2022
Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial. PLoS neglected tropical diseases, 2023, Volume: 17, Issue:2 Topics: Animals; Antiprotozoal Agents; Dogs; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saline Solution; Ulcer	2023
A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 08-22, Volume: 77, Issue:4 Topics: Antiprotozoal Agents; Brazil; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2023
Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil. PloS one, 2017, Volume: 12, Issue:5 Topics: Brazil; Dose-Response Relationship, Drug; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2017
Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial. Memorias do Instituto Oswaldo Cruz, 2018, Jun-21, Volume: 113, Issue:9 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult	2018
Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial. PloS one, 2013, Volume: 8, Issue:6 Topics: Adolescent; Adult; Antiprotozoal Agents; Bandages; Child; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Young Adult	2013
A comparative study between the efficacy of oral cimetidine and low-dose systemic meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2015, Volume: 54, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Antiprotozoal Agents; Child; Cimetidine; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome; Young Adult	2015
Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis. Dermatologic therapy, 2016, Volume: 29, Issue:5 Topics: Acute Disease; Administration, Cutaneous; Adolescent; Adult; Antiprotozoal Agents; Azithromycin; Child; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Young Adult	2016
Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis. Acta dermatovenerologica Croatica : ADC, 2008, Volume: 16, Issue:2 Topics: Adolescent; Adult; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome	2008
Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. The American journal of tropical medicine and hygiene, 2009, Volume: 80, Issue:2 Topics: Antiprotozoal Agents; Child; Child, Preschool; Cryotherapy; Female; Humans; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2009
A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis. Journal of vector borne diseases, 2008, Volume: 45, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Omeprazole; Organometallic Compounds; Treatment Outcome; Young Adult	2008
Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis. International journal of dermatology, 2009, Volume: 48, Issue:7 Topics: Adult; Animals; Antiprotozoal Agents; Endemic Diseases; Humans; Insect Bites and Stings; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pakistan; Psychodidae; Young Adult	2009
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Veterinary dermatology, 2009, Volume: 20, Issue:5-6 Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2009
A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis. The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Colombia; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nitric Oxide; Organometallic Compounds; Treatment Outcome; Young Adult	2010
Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:5 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Injections, Intralesional; Laser Therapy; Lasers, Gas; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Time Factors; Treatment Outcome; Young Adult	2011
Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:2 Topics: Adult; Antiprotozoal Agents; Capsules; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Phosphorylcholine; Young Adult	2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis. Vaccine, 2010, Sep-14, Volume: 28, Issue:40 Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Protozoan; Antibody Formation; Antigens, Protozoan; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polyproteins; Protozoan Vaccines; Recombinant Proteins; Young Adult	2010
Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun. International journal of dermatology, 2010, Volume: 49, Issue:9 Topics: Acute Disease; Adolescent; Adult; Child; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesotherapy; Organometallic Compounds; Pain; Treatment Outcome; Young Adult	2010
Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:4 Topics: Adolescent; Adult; Age Factors; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Medication Adherence; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult	2011
Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:4 Topics: Adolescent; Adult; Anthelmintics; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helminthiasis; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult	2011
A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:3 Topics: Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Pilot Projects; Treatment Outcome	2012
Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children. The Journal of infectious diseases, 2012, Feb-15, Volume: 205, Issue:4 Topics: Administration, Oral; Antiprotozoal Agents; Child; Child, Preschool; Colombia; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Treatment Failure	2012
Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial. Military medicine, 2012, Volume: 177, Issue:3 Topics: Adolescent; Adult; Afghan Campaign 2001-; Aged; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Hyperthermia, Induced; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult	2012
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. Trials, 2012, May-17, Volume: 13 Topics: Adult; Aged; Antiprotozoal Agents; Chi-Square Distribution; Colombia; Drug Administration Schedule; Female; Health Facilities; Humans; Hyperthermia, Induced; Injections, Intramuscular; Kaplan-Meier Estimate; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Facilities; Organometallic Compounds; Recurrence; Time Factors; Treatment Outcome	2012
Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial. International journal of dermatology, 2012, Volume: 51, Issue:12 Topics: Administration, Oral; Adult; Allopurinol; Anti-Bacterial Agents; Antimetabolites; Antiprotozoal Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2012
Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate. International journal of dermatology, 2002, Volume: 41, Issue:7 Topics: Adolescent; Adult; Allopurinol; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2002
Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2002, Volume: 41, Issue:8 Topics: Administration, Oral; Adolescent; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2002
Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. The Journal of dermatological treatment, 2001, Volume: 12, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Ketoconazole; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2001
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis. Infection and immunity, 2002, Volume: 70, Issue:12 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2002
Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Clinical and experimental dermatology, 2003, Volume: 28, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin; Treatment Outcome	2003
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. International journal of dermatology, 2004, Volume: 43, Issue:4 Topics: Adult; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2004
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta tropica, 2004, Volume: 91, Issue:2 Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Double-Blind Method; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Urea	2004
Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology (Basel, Switzerland), 2004, Volume: 209, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antiprotozoal Agents; Case-Control Studies; Child; Child, Preschool; Double-Blind Method; Female; Humans; Injections, Intralesional; Injections, Subcutaneous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Sulfate	2004
Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2004, Volume: 43, Issue:10 Topics: Adolescent; Adult; Antiprotozoal Agents; Carbon Dioxide; Child; Female; Humans; Laser Therapy; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2004
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2005, Volume: 72, Issue:2 Topics: Adult; Animals; Antiprotozoal Agents; Female; Humans; Infusions, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Peru; Treatment Outcome	2005
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-15, Volume: 40, Issue:10 Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Antiprotozoal Agents; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imiquimod; Infant; Injections, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Peru	2005
Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, Volume: 100, Issue:7 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Cytokines; Female; Hot Temperature; Humans; Interferon-gamma; Interleukin-10; Interleukin-5; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Tumor Necrosis Factor-alpha	2006
Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis. International journal of dermatology, 2005, Volume: 44, Issue:12 Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Child; Female; Humans; Injections, Intralesional; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Ointments; Organometallic Compounds; Paromomycin; Treatment Outcome	2005
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS medicine, 2006, Volume: 3, Issue:5 Topics: Adult; Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2006
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2006, Volume: 45, Issue:7 Topics: Adolescent; Adult; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentoxifylline; Treatment Outcome	2006
Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2006, Volume: 45, Issue:9 Topics: Animals; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Humans; Injections, Intralesional; Iran; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2006
Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol. Veterinary parasitology, 2007, Mar-31, Volume: 144, Issue:3-4 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmaniasis, Cutaneous; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors	2007
Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Archives of dermatology, 2006, Volume: 142, Issue:12 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Animals; Antimony; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Single-Blind Method; Treatment Outcome	2006
Miltefosine in cutaneous leishmaniasis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2007, Volume: 17, Issue:3 Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2007
Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clinical and experimental dermatology, 2007, Volume: 32, Issue:4 Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Hot Temperature; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiofrequency Therapy	2007
Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis. BMC complementary and alternative medicine, 2007, Apr-27, Volume: 7 Topics: Antiprotozoal Agents; Drug Therapy, Combination; Honey; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Treatment Outcome	2007
Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jun-15, Volume: 44, Issue:12 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Animals; Antiprotozoal Agents; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Injections, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pilot Projects; Treatment Outcome	2007
Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta tropica, 2007, Volume: 103, Issue:1 Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Female; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Zoonoses	2007
Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2007, Volume: 77, Issue:1 Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Severity of Illness Index; Treatment Outcome	2007
A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. The American journal of tropical medicine and hygiene, 2007, Volume: 77, Issue:4 Topics: Administration, Oral; Adult; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Argentina; Azithromycin; Endemic Diseases; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2007
Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2008, Volume: 78, Issue:2 Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Bolivia; Child; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Time Factors; Treatment Outcome	2008
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin	1995
Treatment of recurrent cutaneous Leishmaniasis. International journal of dermatology, 1995, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Allopurinol; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	1995
Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:3 Topics: Adolescent; Adult; Drug Administration Schedule; Guatemala; Humans; Interferon-gamma; Leishmaniasis, Cutaneous; Male; Meglumine; Recombinant Proteins	1994
Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Colombia; Follow-Up Studies; Humans; Injections, Intramuscular; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Male; Meglumine; Pentamidine; Treatment Outcome	1993
Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Annals of internal medicine, 1997, Feb-01, Volume: 126, Issue:3 Topics: Adult; Allopurinol; Antimetabolites; Antimony; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Failure	1997
Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens. Pathologie-biologie, 1997, Volume: 45, Issue:6 Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1997
A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years). The American journal of tropical medicine and hygiene, 1997, Volume: 57, Issue:6 Topics: Adolescent; Adult; Age Factors; Animals; Antiprotozoal Agents; Brazil; Child; Female; Follow-Up Studies; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mucous Membrane; Organometallic Compounds; Recurrence; Treatment Failure	1997
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:1 Topics: Antiprotozoal Agents; Benzethonium; Double-Blind Method; Drug Therapy, Combination; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin	1998
Evaluating the efficacy of allopurinol for the treatment of cutaneous leishmaniasis. International journal of dermatology, 1997, Volume: 36, Issue:12 Topics: Adolescent; Adult; Allopurinol; Antimetabolites, Antineoplastic; Brazil; Child; Evaluation Studies as Topic; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Meglumine; Middle Aged; Mucous Membrane; Treatment Outcome; Ulcer; Uric Acid	1997
Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration. Annals of tropical medicine and parasitology, 1997, Volume: 91, Issue:8 Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	1997
Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis. International journal of dermatology, 1999, Volume: 38, Issue:8 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	1999
A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran. International journal of dermatology, 1999, Volume: 38, Issue:8 Topics: Administration, Topical; Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Plant Extracts; Treatment Outcome	1999
Clinical follow-up examination after treatment of canine leishmaniasis. The Tokai journal of experimental and clinical medicine, 1998, Volume: 23, Issue:6 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	1998
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Dec-01, Volume: 33, Issue:11 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Imiquimod; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2001
Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. International journal of dermatology, 2002, Volume: 41, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunotherapy, Active; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2002
Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil. Parassitologia, 1992, Volume: 34, Issue:1-3 Topics: Adolescent; Adult; Aged; Animals; Brazil; Child; Child, Preschool; Female; Humans; Immunotherapy, Active; Leishmania; Leishmania guyanensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Protozoan Vaccines	1992
Allopurinol in the treatment of American cutaneous leishmaniasis. The New England journal of medicine, 1992, Aug-13, Volume: 327, Issue:7 Topics: Allopurinol; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992
Allopurinol in the treatment of American cutaneous leishmaniasis. The New England journal of medicine, 1992, Mar-12, Volume: 326, Issue:11 Topics: Adolescent; Adult; Allopurinol; Antimony; Antiprotozoal Agents; Child, Preschool; Developing Countries; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992

Other Studies

265 other study(ies) available for meglumine and Leishmaniasis, Cutaneous

Article	Year
Positivity, diagnosis and treatment follow-up of cutaneous leishmaniasis in war-affected areas of Bajaur, Pakistan. Parasitology research, 2022, Volume: 121, Issue:3 Topics: Adolescent; Animals; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Organometallic Compounds; Pakistan	2022
Intralesional injections of meglumine antimoniate to treat complex facial leishmania infantum acquired in Spain: a case report. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:7 Topics: Antiprotozoal Agents; Humans; Injections, Intralesional; Leishmania infantum; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Treatment Outcome	2022
Antiproliferative properties of Turmerone on Leishmania major: Modes of action confirmed by antioxidative and immunomodulatory roles. Comparative immunology, microbiology and infectious diseases, 2022, Volume: 84 Topics: Animals; Antioxidants; Antiprotozoal Agents; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Molecular Docking Simulation; Organometallic Compounds	2022
Systemic meglumine antimoniate-induced severe dilated cardiomyopathy. Dermatologic therapy, 2022, Volume: 35, Issue:12 Topics: Antiprotozoal Agents; Cardiomyopathy, Dilated; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2022
"It's not all about the disease": do treatment and socioeconomic status affect perceived impact and satisfaction of patients treated for cutaneous leishmaniasis? Revista da Sociedade Brasileira de Medicina Tropical, 2023, Volume: 56 Topics: Antiprotozoal Agents; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Satisfaction; Social Class	2023
Treatment of Cutaneous Leishmaniasis with Allopurinol Plus Itraconazole in Iran. The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6 Topics: Allopurinol; Antiprotozoal Agents; Humans; Iran; Itraconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2023
Treatment of Localized Cutaneous Leishmaniasis With Intralesional Meglumine Antimoniate and Photodynamic Therapy. Actas dermo-sifiliograficas, 2020, Volume: 111, Issue:10 Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Photochemotherapy	2020
Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B. Journal of travel medicine, 2021, 08-27, Volume: 28, Issue:6 Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Ulcer	2021
Evaluating the effect of oral clarithromycin on acute cutaneous leishmaniasis lesions compared with systemic glucantime. The Journal of dermatological treatment, 2022, Volume: 33, Issue:3 Topics: Antiprotozoal Agents; Clarithromycin; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2022
A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis. International journal for parasitology. Drugs and drug resistance, 2020, Volume: 14 Topics: Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Organometallic Compounds; Prospective Studies; Retrospective Studies; Treatment Outcome	2020
Unusual manifestation of genital cutaneous leishmaniasis in an immunocompetent patient from São Paulo, Brazil: A case report. Revista da Sociedade Brasileira de Medicina Tropical, 2021, Volume: 54 Topics: Adult; Antiprotozoal Agents; Brazil; Genitalia; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction	2021
Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:4 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Colombia; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Risk Factors; Treatment Failure; Young Adult	2017
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:4 Topics: Administration, Oral; Antiprotozoal Agents; Caregivers; Child; Child, Preschool; Cost-Benefit Analysis; Directly Observed Therapy; Drug Costs; Female; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Monte Carlo Method; Organometallic Compounds; Phosphorylcholine; Sensitivity and Specificity; Treatment Outcome; United States	2017
Leishmaniasis of the Feet Sole: A Case Report. Turkiye parazitolojii dergisi, 2017, Volume: 41, Issue:1 Topics: Adult; Antiprotozoal Agents; Female; Foot Dermatoses; Forefoot, Human; Humans; Injections, Intramuscular; Iran; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2017
Leishmanial dactylitis: an unusual clinical presentation. Dermatology online journal, 2017, May-15, Volume: 23, Issue:5 Topics: Aged; Antiprotozoal Agents; Diagnosis, Differential; Endemic Diseases; Female; Fingers; Humans; Iran; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Travel-Related Illness	2017
Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 2017, Jun-01, Volume: 59 Topics: Antiprotozoal Agents; Brazil; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2017
Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis. International journal of antimicrobial agents, 2017, Volume: 50, Issue:2 Topics: Amiodarone; Animals; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Hindlimb; Histocytochemistry; Itraconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin; Treatment Outcome	2017
Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae). Phytotherapy research : PTR, 2017, Volume: 31, Issue:9 Topics: Animals; Antiprotozoal Agents; Asteraceae; Female; Leishmania; Leishmania mexicana; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Oils, Volatile; Organometallic Compounds; Plant Leaves	2017
Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study. Parasite (Paris, France), 2017, Volume: 24 Topics: Adolescent; Adult; Age Factors; Antiprotozoal Agents; Brazil; Child; Cluster Analysis; Cohort Studies; DNA, Kinetoplast; Electrophoresis, Agar Gel; Female; Genotype; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phenotype; Pilot Projects; Polymerase Chain Reaction; Polymorphism, Genetic; Young Adult	2017
Intralesional Infiltration with Meglumine Antimoniate for the Treatment of Leishmaniasis Recidiva Cutis in Ecuador. The American journal of tropical medicine and hygiene, 2017, Volume: 97, Issue:5 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Ecuador; Female; Follow-Up Studies; Humans; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult	2017
Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). Memorias do Instituto Oswaldo Cruz, 2017, Volume: 112, Issue:12 Topics: Adult; Antiprotozoal Agents; Cohort Studies; Female; Humans; Incidence; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome	2017
In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis. Parasitology research, 2018, Volume: 117, Issue:1 Topics: Administration, Topical; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Female; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Salts; Skin; Toxicity Tests	2018
Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment. Memorias do Instituto Oswaldo Cruz, 2018, Volume: 113, Issue:2 Topics: Antiprotozoal Agents; Clinical Protocols; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reproducibility of Results	2018
Antimonial susceptibility and in vivo behaviour of Leishmania major isolates collected in Algeria before and after treatment. Acta tropica, 2018, Volume: 180 Topics: Adult; Algeria; Animals; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Middle Aged; Organometallic Compounds; Treatment Failure; Young Adult	2018
Cutaneous Leishmaniasis in Pediatric Patients in a Single Tertiary Hospital in Ankara. Turkiye parazitolojii dergisi, 2017, Volume: 41, Issue:4 Topics: Antiprotozoal Agents; Child; Child Health Services; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Male; Medical Records; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Tertiary Care Centers; Turkey	2017
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia. BMC public health, 2018, 01-29, Volume: 18, Issue:1 Topics: Colombia; Cost-Benefit Analysis; Disabled Persons; Humans; Hyperthermia, Induced; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quality-Adjusted Life Years; Treatment Outcome	2018
Epidemiological Aspects of Cutaneous Leishmaniasis during 2009-2016 in Kashan City, Central Iran. The Korean journal of parasitology, 2018, Volume: 56, Issue:1 Topics: Adolescent; Adult; Age Factors; Animals; Child; Child, Preschool; Disease Reservoirs; Disease Vectors; Female; Health Education; Humans; Incidence; Infant; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Seasons; Time Factors; Young Adult	2018
Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain. The Journal of pharmacy and pharmacology, 2018, Volume: 70, Issue:6 Topics: Acetylglucosaminidase; Animals; Chronic Pain; Cytokines; Freund's Adjuvant; Inflammation; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peroxidase; Skin	2018
Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study. Turkiye parazitolojii dergisi, 2018, Volume: 42, Issue:1 Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Pilot Projects; Practice Guidelines as Topic; Turkey	2018
Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil. Acta tropica, 2013, Volume: 126, Issue:2 Topics: Amino Acid Substitution; Animals; Antiprotozoal Agents; Base Sequence; Brazil; DNA, Protozoan; Drug Resistance; Genetic Markers; HSP70 Heat-Shock Proteins; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Molecular Sequence Data; Mutation; Organometallic Compounds; Polymorphism, Genetic; Prognosis; Protozoan Proteins; Sequence Analysis, DNA; Treatment Outcome	2013
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study. Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:3 Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibroblasts; Humans; Immunomodulation; Interleukins; Lactic Acid; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Povidone; Wound Healing	2013
Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran. Journal of infection and public health, 2013, Volume: 6, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intralesional; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult	2013
Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study. Drug development and industrial pharmacy, 2014, Volume: 40, Issue:6 Topics: Antiprotozoal Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Microscopy, Electron, Scanning; Microspheres; Organometallic Compounds; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Surface Properties	2014
Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment. Infection, 2013, Volume: 41, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Retrospective Studies; Species Specificity; Switzerland; Travel; Treatment Outcome; Young Adult	2013
Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro. Experimental parasitology, 2013, Volume: 135, Issue:2 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Apoptosis; Cytokines; DNA Fragmentation; Female; Immunologic Factors; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Lignans; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Nitric Oxide; Organometallic Compounds	2013
Cutaneous leishmaniasis "chiclero's ulcer" in subtropical Ecuador. The American journal of tropical medicine and hygiene, 2013, Volume: 89, Issue:2 Topics: Administration, Topical; Adolescent; Antiprotozoal Agents; Ear; Ecuador; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Ulcer; Thimerosal	2013
[Pain and inflammation of the pinna]. Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32, Issue:2 Topics: Adult; Antiprotozoal Agents; Ear, External; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Otitis Externa; Spain	2014
Slow-growing scaly erythematous plaque on the face and scalp of an elderly woman. Actas dermo-sifiliograficas, 2013, Volume: 104, Issue:8 Topics: Aged, 80 and over; Antibodies, Protozoan; Antiprotozoal Agents; Erythema; Facial Dermatoses; False Negative Reactions; Female; Humans; Inclusion Bodies; Leishmania infantum; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Scalp Dermatoses; Staining and Labeling	2013
[Chronic facial ulceration in France and potential involvement of Leishmania infantum cutaneous leishmaniasis]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:11 Topics: Antiprotozoal Agents; Child; Combined Modality Therapy; Cryotherapy; Facial Dermatoses; Female; France; Humans; Injections, Intralesional; Leishmania infantum; Leishmaniasis, Cutaneous; Mediterranean Region; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2013
Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:7 Topics: Adult; Antiprotozoal Agents; Antirheumatic Agents; Arthritis, Psoriatic; Combined Modality Therapy; Cryotherapy; Humans; Infliximab; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2014
An atypical case of cutaneous leishmaniasis caused by Leishmania infantum in Portugal. Dermatology online journal, 2013, Nov-15, Volume: 19, Issue:11 Topics: Aged; Antiprotozoal Agents; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Portugal	2013
Nonhealing ulcers: an infectious viewpoint. Mayo Clinic proceedings, 2014, Volume: 89, Issue:1 Topics: Antiprotozoal Agents; Biopsy; Diagnosis, Differential; Female; Humans; Iran; Leg Ulcer; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Wound Healing	2014
[Cutaneous leishmaniasis and multidermatomic herpes zoster]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2013, Volume: 30, Issue:6 Topics: Adult; Antiprotozoal Agents; Female; Herpes Zoster; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases, Viral	2013
Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice. Drug research, 2015, Volume: 65, Issue:3 Topics: Animals; Drug Therapy, Combination; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Silymarin	2015
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult	2015
Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. Experimental parasitology, 2014, Volume: 143 Topics: Administration, Topical; Animals; Antiprotozoal Agents; Cell Line; Female; Leishmania major; Leishmaniasis, Cutaneous; Liposomes; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Random Allocation; Skin; Spleen	2014
Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran. Acta medica Iranica, 2014, Volume: 52, Issue:3 Topics: Antiprotozoal Agents; Antitubercular Agents; Child; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pleural Effusion; Polymerase Chain Reaction; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2014
Cutaneous Leishmaniasis with HIV. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2014, Volume: 24 Suppl 2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; HIV Infections; Humans; Immunocompromised Host; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2014
Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Algeria; Antiprotozoal Agents; Drug Resistance; France; Gene Expression Regulation; Genotype; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Metabolic Networks and Pathways; Organometallic Compounds; Parasitic Sensitivity Tests; Phenotype; Protozoan Proteins; Tunisia	2014
In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis. The Journal of parasitology, 2014, Volume: 100, Issue:6 Topics: Animals; Antiprotozoal Agents; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Phosphorylcholine; Spleen	2014
A 45 year old man with an ulcerated nodule on his right leg. BMJ (Clinical research ed.), 2014, Sep-08, Volume: 349 Topics: Antiprotozoal Agents; Humans; Injections, Intralesional; Leg Ulcer; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2014
Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerging infectious diseases, 2014, Volume: 20, Issue:10 Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Lebanon; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Refugees; Syria; Young Adult	2014
[Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment]. Turkiye parazitolojii dergisi, 2014, Volume: 38, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Diptera; DNA, Intergenic; DNA, Protozoan; Drug Resistance; Humans; Larva; Leishmania; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2014
[Clinical, epidemiological and evolutionary aspects in 157 cases of cutaneous leishmaniasis in Morocco]. The Pan African medical journal, 2014, Volume: 17 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Cicatrix; Disease Progression; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Morocco; Nitrogen; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Young Adult	2014
Cutaneous leishmaniasis: 20 years' experience in a Spanish tertiary care hospital. Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:4 Topics: Adolescent; Adult; Africa, Northern; Aged; Antiprotozoal Agents; Comorbidity; Emigrants and Immigrants; Endemic Diseases; Female; HIV Infections; Humans; Immunocompromised Host; Latin America; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Spain; Tertiary Care Centers; Young Adult	2015
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:2 Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan	2015
[Facial inflammatory cutaneous leishmaniasis or "erysipeloid"]. Annales de dermatologie et de venereologie, 2015, Volume: 142, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Erysipeloid; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Postmenopause	2015
Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy. BMC infectious diseases, 2015, Feb-19, Volume: 15 Topics: Adult; Antigens, Protozoan; Antiprotozoal Agents; Apoptosis; Brazil; CD8-Positive T-Lymphocytes; Cohort Studies; Female; Flow Cytometry; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Young Adult	2015
In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs. Experimental parasitology, 2015, Volume: 154 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line, Tumor; Child; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Meglumine Antimoniate; Naphthoquinones; Organometallic Compounds; Pakistan; Parasitic Sensitivity Tests	2015
[Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy]. Turkiye parazitolojii dergisi, 2015, Volume: 39, Issue:1 Topics: Administration, Intravenous; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Insect Bites and Stings; Insect Vectors; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus	2015
Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2015, Jun-09, Volume: 21, Issue:4 Topics: Antiprotozoal Agents; Child; Female; Humans; Injections, Intralesional; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Outcome Assessment, Health Care; Surveys and Questionnaires; Treatment Outcome	2015
[Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens]. Turkiye parazitolojii dergisi, 2015, Volume: 39, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Child, Preschool; Humans; Iran; Iraq; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Turkey	2015
Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis. The Journal of dermatological treatment, 2016, Volume: 27, Issue:1 Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Young Adult	2016
The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway. International immunopharmacology, 2015, Volume: 28, Issue:1 Topics: Animals; Antiprotozoal Agents; Drug Therapy, Combination; Interleukin-10; Interleukin-12; Interleukin-1beta; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; NF-kappa B; Organometallic Compounds; Phenyl Ethers; Quinazolines; Signal Transduction	2015
Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major. Parasitology research, 2015, Volume: 114, Issue:12 Topics: Animals; Antiprotozoal Agents; Chitosan; Female; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome	2015
Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:12 Topics: Administration, Oral; Administration, Topical; Animals; Antiprotozoal Agents; Appointments and Schedules; Disease Models, Animal; Drug Therapy, Combination; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Paromomycin; Phosphorylcholine; Skin; Spleen; Treatment Outcome	2015
[Erysipeloid cutaneous leishmaniasis: about a clinical observation]. The Pan African medical journal, 2015, Volume: 21 Topics: Adult; Antiprotozoal Agents; Erysipeloid; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds	2015
Cutaneous leishmaniasis mimicking granulomatous cheilitis and treated successfully with oral fluconazole in a boy. Annals of parasitology, 2015, Volume: 61, Issue:3 Topics: Antiprotozoal Agents; Child; Diagnosis, Differential; Fluconazole; Humans; Leishmaniasis, Cutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Melkersson-Rosenthal Syndrome; Organometallic Compounds; Treatment Outcome	2015
Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications. Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:4 Topics: Adolescent; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Organometallic Compounds	2015
Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice. Parasitology research, 2016, Volume: 115, Issue:4 Topics: Animals; Cytokines; Inflammation; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propolis	2016
Tumour Necrosis Factor-alpha (TNF-α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases. Parasite immunology, 2016, Volume: 38, Issue:4 Topics: Adult; Antiprotozoal Agents; Case-Control Studies; Female; Humans; Interleukin-17; Interleukin-22; Interleukins; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Receptors, Tumor Necrosis Factor, Type I; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult	2016
In Vitro and In Vivo Antileishmanial Activities of Pistacia vera Essential Oil. Planta medica, 2016, Volume: 82, Issue:4 Topics: Animals; Antiprotozoal Agents; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Oils, Volatile; Organometallic Compounds; Pistacia	2016
Cutaneous Leishmaniasis: An Overlooked Etiology of Midfacial Destructive Lesions. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:2 Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Young Adult	2016
Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure. Parasite immunology, 2016, Volume: 38, Issue:4 Topics: Adult; Antiprotozoal Agents; CD4 Lymphocyte Count; Cell Degranulation; Cells, Cultured; Cytotoxicity, Immunologic; Female; Humans; Killer Cells, Natural; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Natural Killer T-Cells; Organometallic Compounds; Young Adult	2016
Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology. BioMed research international, 2016, Volume: 2016 Topics: Algeria; Animals; Disease Models, Animal; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Spleen	2016
AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT. Revista do Instituto de Medicina Tropical de Sao Paulo, 2016, Volume: 58 Topics: Amphotericin B; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2016
Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis. Dermatology online journal, 2016, Mar-16, Volume: 22, Issue:3 Topics: Antiprotozoal Agents; Facial Dermatoses; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin	2016
In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil. Experimental parasitology, 2016, Volume: 167 Topics: Adult; Aged; Animals; Antiprotozoal Agents; Brazil; Complement System Proteins; Cytokines; DNA, Protozoan; Female; Guinea Pigs; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Middle Aged; Nitric Oxide; Organometallic Compounds; Random Amplified Polymorphic DNA Technique	2016
Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:1 Topics: Adult; Drug Hypersensitivity; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2017
Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:5 Topics: Adult; Antiprotozoal Agents; Cohort Studies; Cross-Sectional Studies; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Treatment Failure; U937 Cells; Young Adult	2016
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis. International journal of nanomedicine, 2016, Volume: 11 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Hydrophobic and Hydrophilic Interactions; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Microscopy, Atomic Force; Nanoparticles; Organometallic Compounds; Scattering, Small Angle; Solvents; Treatment Outcome; X-Ray Diffraction	2016
Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR. International journal of dermatology, 2016, Volume: 55, Issue:9 Topics: Antiprotozoal Agents; Cross-Sectional Studies; Down-Regulation; Drug Resistance; Gene Expression; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protein Kinase C; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction	2016
[Polymorphic lesions of cutaneous leishmaniasis revealing human immunodeficiency virus infection]. Medecine et maladies infectieuses, 2016, Volume: 46, Issue:7 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Endemic Diseases; Female; Fluconazole; Herpes Zoster; Humans; Immunocompromised Host; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Recurrence; Viremia; Young Adult	2016
Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre. Memorias do Instituto Oswaldo Cruz, 2016, Volume: 111, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Young Adult	2016
Long-standing Erythematous Plaque in a Perianal Skin Fold. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:5 Topics: Aged, 80 and over; Antiprotozoal Agents; Buttocks; Erythema; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2017
Topical Treatment of Leishmania tropica Infection Using (-)-α-Bisabolol Ointment in a Hamster Model: Effectiveness and Safety Assessment. Journal of natural products, 2016, 09-23, Volume: 79, Issue:9 Topics: Administration, Oral; Animals; Antiprotozoal Agents; Cricetinae; Cytochrome P-450 CYP2D6 Inhibitors; Disease Models, Animal; Injections, Intralesional; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Molecular Structure; Monocyclic Sesquiterpenes; Organometallic Compounds; Sesquiterpenes; Skin; Stereoisomerism	2016
DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis. Scientific reports, 2016, 12-06, Volume: 6 Topics: Administration, Cutaneous; Animals; Antiprotozoal Agents; Cellulose; Cytokines; Ditiocarb; Drug Therapy, Combination; Female; Gluconacetobacter; Humans; Injections, Intraperitoneal; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Primary Cell Culture; Superoxide Dismutase-1; Superoxides	2016
The pulsed dye laser is more effective and rapidly acting than intralesional meglumine antimoniate therapy for cutaneous leishmaniasis. The Journal of dermatological treatment, 2017, Volume: 28, Issue:5 Topics: Adult; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Lasers, Dye; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2017
Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients. PloS one, 2017, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Audiometry, Pure-Tone; Auditory Threshold; Brazil; Cochlea; Female; Hearing; Humans; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Otoacoustic Emissions, Spontaneous; Prospective Studies; Young Adult	2017
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles	2017
Evolution of cutaneous leishmaniasis in the last 30 years in a tertiary hospital of the European Mediterranean coast. International journal of dermatology, 2017, Volume: 56, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Aged; Amphotericin B; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Kidney Transplantation; Leishmaniasis, Cutaneous; Male; Mediterranean Region; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Tumor Necrosis Factor-alpha	2017
Activity of hydroxyurea against Leishmania mexicana. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Animals; Antiprotozoal Agents; Cell Cycle; Disease Models, Animal; Humans; Hydroxyurea; In Vitro Techniques; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests	2008
Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. The American journal of tropical medicine and hygiene, 2008, Volume: 79, Issue:3 Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Interferon-gamma; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2008
Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report). The Korean journal of parasitology, 2008, Volume: 46, Issue:3 Topics: Administration, Topical; Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trichloroacetic Acid	2008
[Outbreak of cutaneous leishmaniasis: about 213 cases in the province of Tizi-Ouzou]. Pathologie-biologie, 2009, Volume: 57, Issue:1 Topics: Adolescent; Adult; Aged; Algeria; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult	2009
Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice. Travel medicine and infectious disease, 2008, Volume: 6, Issue:6 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Colombia; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Travel; Treatment Outcome; Venezuela; Young Adult	2008
Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Animals; Antiprotozoal Agents; Blood Cell Count; Leishmania mexicana; Leishmaniasis, Cutaneous; Lymph Nodes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Nitric Oxide; Organometallic Compounds; Structure-Activity Relationship; Thiadiazoles	2009
The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:7 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Colombia; Female; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult	2009
[Adverse events related to systemic treatment using Glucantime for cutaneous leishmaniasis: a report from Tunisia]. Medecine tropicale : revue du Corps de sante colonial, 2008, Volume: 68, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Tunisia; Young Adult	2008
Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime. Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:11 Topics: Administration, Oral; Adult; Animals; Antimony; Antiprotozoal Agents; Atrial Premature Complexes; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Prospective Studies; Ventricular Premature Complexes	2008
Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment. Journal of clinical laboratory analysis, 2009, Volume: 23, Issue:1 Topics: Animals; Antigens, Protozoan; Case-Control Studies; Concanavalin A; Female; Follow-Up Studies; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Statistics, Nonparametric; Treatment Outcome	2009
Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice. Journal of vector borne diseases, 2008, Volume: 45, Issue:4 Topics: Achillea; Administration, Cutaneous; Animals; Antiprotozoal Agents; Female; Injections, Intraperitoneal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phytotherapy; Plant Extracts; Propolis; Thymus Plant; Treatment Outcome	2008
Localized cutaneous leishmaniasis of the plantar region: a 40-year outcome. Dermatology online journal, 2008, Dec-15, Volume: 14, Issue:12 Topics: Aged; Animals; Antiprotozoal Agents; DNA, Protozoan; Drug Administration Schedule; Foot; Gene Amplification; Humans; Injections, Intravenous; Leishmania; Leishmaniasis, Cutaneous; Male; Medical Records; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2008
Childhood cutaneous leishmaniasis: Experience of a Moroccan unit of dermatology. Dermatology online journal, 2008, Dec-15, Volume: 14, Issue:12 Topics: Antiprotozoal Agents; Child; Dermatology; Face; Female; Hospitals, University; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Retrospective Studies; Sex Distribution; Treatment Outcome	2008
[Cutaneous leishmaniasis in rheumatoid arthritis]. La Revue de medecine interne, 2009, Volume: 30, Issue:7 Topics: Adult; Antiprotozoal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds; Prednisone	2009
[Unilateral erythema nodosum and homolateral cutaneous leishmaniasis]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:9 Topics: Biopsy; Drug Hypersensitivity; Erythema Nodosum; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Middle Aged	2009
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:7 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; HIV Infections; HIV-1; Humans; Infant; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Socioeconomic Factors; Young Adult	2009
Rhinophymous leishmaniasis: A new variant. Dermatology online journal, 2009, Mar-15, Volume: 15, Issue:3 Topics: Aged; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rhinophyma	2009
[Raised tattoos in a human-immunodeficiency-virus-infected patient]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine	2009
Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:7 Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Brazil; Facial Dermatoses; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pregnancy; Pregnancy Complications, Parasitic; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome; Young Adult	2009
The potential utility of green tea extract as a novel treatment for cutaneous leishmaniasis. Journal of alternative and complementary medicine (New York, N.Y.), 2009, Volume: 15, Issue:8 Topics: Animals; Antiprotozoal Agents; Camellia sinensis; Drug Resistance; Flavonoids; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Tea	2009
[Mucosal complication of cutaneous leishmaniasis]. Biomedica : revista del Instituto Nacional de Salud, 2009, Volume: 29, Issue:1 Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds; Phosphorylcholine	2009
Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta). Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Kidney; Leishmania braziliensis; Leishmaniasis, Cutaneous; Liver; Macaca mulatta; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen	2010
Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010, Volume: 104, Issue:1 Topics: Antiprotozoal Agents; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Pentamidine	2010
In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Tropical medicine & international health : TM & IH, 2010, Volume: 15, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests	2010
Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab. Dermatology (Basel, Switzerland), 2010, Volume: 220, Issue:1 Topics: Antibodies, Monoclonal; Antiprotozoal Agents; Antirheumatic Agents; Humans; Infliximab; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha	2010
Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate. Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:12 Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Treatment Outcome	2009
Cutaneous leishmaniasis of the lid: a report of nine cases. Korean journal of ophthalmology : KJO, 2010, Volume: 24, Issue:1 Topics: Adolescent; Adult; Child; Eyelid Diseases; Eyelids; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2010
American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil. Journal of the American Geriatrics Society, 2010, Volume: 58, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2010
[Side effects of meglumine antimoniate in cutaneous leishmaniasis: 15 cases]. La Tunisie medicale, 2010, Volume: 88, Issue:1 Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome	2010
A case with two unusual findings: cutaneous leishmaniasis presenting as panniculitis and pericarditis after antimony therapy. International journal of dermatology, 2010, Volume: 49, Issue:3 Topics: Antiprotozoal Agents; Chest Pain; DNA, Protozoan; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Panniculitis; Pericarditis	2010
Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2010, Volume: 10, Issue:6 Topics: Animals; Antimony; Antiprotozoal Agents; Brazil; Drug Resistance; Gene Expression Profiling; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasites; Treatment Outcome	2010
Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006. International journal of dermatology, 2010, Volume: 49, Issue:5 Topics: Adolescent; Allopurinol; Child; Face; Female; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence	2010
Childhood and adult cutaneous leishmaniasis in Tunisia. International journal of dermatology, 2010, Volume: 49, Issue:7 Topics: Adolescent; Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Sex Distribution; Tunisia; Young Adult	2010
Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2010, Volume: 20, Issue:7 Topics: Antimony; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2010
Leishmania amazonensis META2 protein confers protection against heat shock and oxidative stress. Experimental parasitology, 2011, Volume: 127, Issue:1 Topics: Animals; Antiprotozoal Agents; Blotting, Western; Fluorescent Antibody Technique; Gene Expression Regulation; Hot Temperature; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Mutation; Novobiocin; Nucleic Acid Synthesis Inhibitors; Organometallic Compounds; Oxidative Stress; Protozoan Proteins; Recombinant Proteins; RNA Interference; Trypanosoma brucei brucei	2011
Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2010, Volume: 16, Issue:3 Topics: Adolescent; Adult; Antiprotozoal Agents; Chronic Disease; Cicatrix; Diagnosis, Differential; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Lupus Vulgaris; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Treatment Outcome	2010
Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression. Clinical and experimental immunology, 2011, Volume: 163, Issue:2 Topics: Adult; Antimony; Antiprotozoal Agents; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Leishmaniasis, Cutaneous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regeneration; Skin; Transforming Growth Factor beta; Treatment Failure	2011
Unusual form of cutaneous leishmaniasis: erysipeloid form. European annals of otorhinolaryngology, head and neck diseases, 2011, Volume: 128, Issue:2 Topics: Antiprotozoal Agents; Biopsy; Diagnosis, Differential; Erysipeloid; Facial Dermatoses; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Skin	2011
[Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:6 Topics: Adolescent; Anti-Inflammatory Agents; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methylprednisolone; Organometallic Compounds; Panuveitis; Prednisone	2011
Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis. The Southeast Asian journal of tropical medicine and public health, 2011, Volume: 42, Issue:3 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Female; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polymerase Chain Reaction; Treatment Outcome; Young Adult	2011
Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy. Archives of Iranian medicine, 2011, Volume: 14, Issue:4 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminoquinolines; Animals; Antigens, CD; Antigens, CD1; Antigens, CD20; Antigens, Differentiation, Myelomonocytic; Antiprotozoal Agents; B-Lymphocytes; CD3 Complex; Child; Dermis; Drug Therapy, Combination; Epidermis; Female; Humans; Imiquimod; Iran; Langerhans Cells; Leishmania tropica; Leishmaniasis, Cutaneous; Lymphocyte Count; Macrophages; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Parasite Load; Single-Blind Method; T-Lymphocytes; Young Adult	2011
An experimental approach to studying the effectiveness and safety of meglumine antimoniate formulations. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2011, Volume: 65, Issue:8 Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Immunomodulation; In Vitro Techniques; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Organometallic Compounds; Species Specificity; Toxicity Tests	2011
Leishmania amazonensis: effects of oral treatment with copaiba oil in mice. Experimental parasitology, 2011, Volume: 129, Issue:2 Topics: Administration, Oral; Administration, Topical; Animals; Antiprotozoal Agents; Cell Membrane; Cell Membrane Permeability; Cyclophosphamide; Erythrocytes; Fabaceae; Flow Cytometry; Humans; Injections, Subcutaneous; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Membrane Potentials; Mice; Mice, Inbred BALB C; Micronucleus Tests; Microscopy, Electron, Scanning; Mitochondria; Mutagens; Organometallic Compounds; Plant Oils	2011
Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma. The American Journal of dermatopathology, 2011, Volume: 33, Issue:6 Topics: Antiprotozoal Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Epithelial Cells; Humans; Hyperplasia; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2011
The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitology research, 2012, Volume: 110, Issue:3 Topics: Animals; Antiprotozoal Agents; Calcium Channel Blockers; Colorimetry; Disease Models, Animal; Drug Synergism; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Verapamil	2012
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:1 Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thiadiazoles; Treatment Outcome	2012
Treatment of imported New World cutaneous leishmaniasis in Germany. International journal of dermatology, 2011, Volume: 50, Issue:11 Topics: Adolescent; Adult; Aged; Amphotericin B; Animals; Antiprotozoal Agents; Female; Germany; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Travel; Young Adult	2011
Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate. Journal of toxicology and environmental health. Part A, 2012, Volume: 75, Issue:2 Topics: Animals; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Erythrocytes; Female; Half-Life; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction; Reproducibility of Results; Spectrophotometry, Atomic; Thyroid Gland; Tissue Distribution	2012
Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice. International journal of antimicrobial agents, 2012, Volume: 39, Issue:4 Topics: Animals; Antiprotozoal Agents; Azure Stains; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasite Load; Phosphorylcholine; Time Factors; Ulcer	2012
Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation. Tropical doctor, 2012, Volume: 42, Issue:2 Topics: Antiprotozoal Agents; Child; Diagnosis, Differential; Facial Dermatoses; Humans; Leishmania; Leishmaniasis, Cutaneous; Lupus Erythematosus, Discoid; Lupus Vulgaris; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Treatment Outcome	2012
Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation? Acta dermato-venereologica, 2013, Volume: 93, Issue:1 Topics: Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Endemic Diseases; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leprosy, Tuberculoid; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult	2013
[Cutaneous leishmaniasis in the military hospital Moulay Ismaïl of Meknes (Morocco): about 49 cases diagnosed between 2005 and 2011]. Pathologie-biologie, 2013, Volume: 61, Issue:2 Topics: Adult; Cryotherapy; Delayed Diagnosis; Female; Geography; Hospitals, Military; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Middle Aged; Morocco; Treatment Outcome; Young Adult	2013
An epidemic outbreak of canine cutaneous leishmaniasis in Colombia caused by Leishmania braziliensis and Leishmania panamensis. The American journal of tropical medicine and hygiene, 2012, Volume: 86, Issue:5 Topics: Animals; Colombia; Disease Outbreaks; Dog Diseases; Dogs; Female; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Male; Meglumine; Military Personnel; Psychodidae	2012
Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2012, Volume: 18, Issue:2 Topics: Antiprotozoal Agents; Cells, Cultured; Drug Resistance, Microbial; Electrophoresis, Gel, Two-Dimensional; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteomics	2012
Renal function evaluation in patients with American cutaneous leishmaniasis after specific treatment with pentavalent antimonial. BMC nephrology, 2012, Jun-20, Volume: 13 Topics: Adult; Antiprotozoal Agents; Female; Humans; Kidney; Kidney Diseases; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult	2012
Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006). The American journal of tropical medicine and hygiene, 2012, Volume: 87, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Statistics, Nonparametric; Urban Population; Young Adult	2012
Meglumine antimonate treatment enhances phagocytosis and TNF-α production by monocytes in human cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2012, Volume: 106, Issue:10 Topics: Antiprotozoal Agents; Brazil; Female; Humans; Hydrogen Peroxide; Interleukin-10; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Monocytes; Organometallic Compounds; Phagocytosis; Tumor Necrosis Factor-alpha	2012
Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2012, Volume: 51, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Antiprotozoal Agents; Child; Child, Preschool; Cross-Sectional Studies; Erythema; Female; Humans; Infant; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Pruritus; Treatment Outcome; Vomiting; Young Adult	2012
Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab. Dermatology online journal, 2012, Sep-15, Volume: 18, Issue:9 Topics: Adalimumab; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds	2012
Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis. Allergy, 2012, Volume: 67, Issue:12 Topics: Adult; Aged; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin Tests	2012
Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure. Cellular immunology, 2012, Volume: 279, Issue:2 Topics: Antigens, Protozoan; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tumor Necrosis Factor-alpha	2012
Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013, Volume: 107, Issue:4 Topics: Antiprotozoal Agents; Brazil; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Outcome Assessment, Health Care; Skin Ulcer	2013
Unusual location of cutaneous leishmaniasis on the hallux in a Brazilian patient. International journal of dermatology, 2002, Volume: 41, Issue:7 Topics: Aged; Animals; Antiprotozoal Agents; Female; Hallux; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiography	2002
Expansion of gammadelta T Cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2002, Volume: 6, Issue:5 Topics: Adult; Aged; Antiprotozoal Agents; Case-Control Studies; Female; Flow Cytometry; Humans; Leishmaniasis, Cutaneous; Lymphocyte Activation; Lymphocyte Count; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; T-Lymphocyte Subsets	2002
Human cutaneous leishmaniasis due to Leishmania infantum in the Sidi Bourouis focus (Northern Tunisia): epidemiological study and isoenzymatic characterization of the parasites. Acta tropica, 2003, Volume: 85, Issue:1 Topics: Aged; Animals; Cells, Cultured; Child, Preschool; Female; Humans; Isoenzymes; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tunisia	2003
Leishmaniasis of the lip. Acta dermato-venereologica, 2002, Volume: 82, Issue:6 Topics: Aged; Antiprotozoal Agents; Azure Stains; Humans; Leishmaniasis, Cutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2002
Post-kala-azar dermal leishmaniasis associated with AIDS. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2002, Volume: 6, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2002
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. International journal of dermatology, 2003, Volume: 42, Issue:3 Topics: Administration, Oral; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentoxifylline; Tumor Necrosis Factor-alpha	2003
Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3 Topics: Adolescent; Antimony; Antiprotozoal Agents; Equipment Design; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2003
High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls. Memorias do Instituto Oswaldo Cruz, 2003, Volume: 98, Issue:1 Topics: Antiprotozoal Agents; Arsenic; Cadmium; Case-Control Studies; Chi-Square Distribution; Drug Contamination; Female; Humans; Hydrogen-Ion Concentration; Lead; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metals, Heavy; Organometallic Compounds; Osmolar Concentration; Statistics, Nonparametric	2003
Detection of new endemic areas of cutaneous leishmaniasis in Pakistan: a 6-year study. International journal of dermatology, 2003, Volume: 42, Issue:7 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Endemic Diseases; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pakistan	2003
Back from the Peace Corps--with skin lesions from South America. The Journal of family practice, 2003, Volume: 52, Issue:7 Topics: Adult; Animals; Antiprotozoal Agents; Diagnosis, Differential; Ecuador; Female; Government Agencies; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Treatment Outcome	2003
Efficacy of 8-bromoguanosine against murine cutaneous leishmaniasis induced with Leishmania amazonensis. Chemotherapy, 2003, Volume: 49, Issue:4 Topics: Alanine Transaminase; Animals; Female; Guanosine; Hematologic Tests; Injections, Intraperitoneal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Organometallic Compounds; Skin Ulcer; Trypanocidal Agents; Urea	2003
The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Annals of tropical medicine and parasitology, 2003, Volume: 97, Issue:5 Topics: Adolescent; Adult; Aged; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2003
[The activity of intramuscular glucantime and of intravenous anthiomaline in the treatment of sylvan American leishmaniasis]. Publication. Cayenne, French Guiana. Institut Pasteur de la Guyane francaise et de l'Inini, 1955, Volume: 16, Issue:353 Topics: Antimony; Furans; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
Rare variants of Cutaneous Leishmaniasis: whitlow, paronychia, and sporotrichoid. International journal of dermatology, 2003, Volume: 42, Issue:10 Topics: Antiprotozoal Agents; Arm; Cryotherapy; Female; Fingers; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pakistan; Paronychia; Sporotrichosis	2003
[Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate]. Bulletin de la Societe de pathologie exotique (1990), 2003, Volume: 96, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Djibouti; Drug Resistance; France; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds	2003
Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1 Topics: Administration, Oral; Animals; Antiprotozoal Agents; beta-Cyclodextrins; Chemical Phenomena; Chemistry, Physical; Cyclodextrins; Injections, Intraperitoneal; Intestinal Absorption; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds	2004
[Treatment of cutaneous leishmaniasis by antimoniate of N-methyl glucamine; 15 personal observations]. Journal de medecine de Lyon, 1950, Sep-05, Volume: 31, Issue:736 Topics: Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1950
[American cutaneo-mucous leishmaniasis; glucantime therapy; preliminary note]. Prensa medica argentina, 1951, Apr-06, Volume: 38, Issue:14 Topics: Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; United States	1951
Multiple leg ulcers in a traveler. Cleveland Clinic journal of medicine, 2004, Volume: 71, Issue:2 Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Azure Stains; Biopsy; Humans; Leg Ulcer; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Travel	2004
Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment. Memorias do Instituto Oswaldo Cruz, 2003, Volume: 98, Issue:8 Topics: Antiprotozoal Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Ulcer	2003
Use of meglumine antimoniate in canine leishmaniasis. The Veterinary record, 2004, Mar-20, Volume: 154, Issue:12 Topics: Adult; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Humans; Infant; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2004
Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey. The Journal of parasitology, 2004, Volume: 90, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Cryosurgery; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Turkey	2004
Emergency initiative to reduce leishmaniasis in Afghanistan. The Lancet. Infectious diseases, 2004, Volume: 4, Issue:10 Topics: Afghanistan; Antimony Sodium Gluconate; Antiprotozoal Agents; Bedding and Linens; Emergency Medical Services; Health Education; Humans; Incidence; International Cooperation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pesticides; Refugees	2004
Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Acta tropica, 2005, Volume: 93, Issue:1 Topics: Adolescent; Adult; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Tests	2005
Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Acta tropica, 2005, Volume: 93, Issue:2 Topics: Administration, Topical; Animals; Antimony Sodium Gluconate; Cricetinae; Female; Gels; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Random Allocation; Statistics, Nonparametric	2005
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application]. Biomedica : revista del Instituto Nacional de Salud, 2004, Volume: 24, Issue:4 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2004
[Glucantime injection: benefit versus toxicity]. Medecine et maladies infectieuses, 2005, Volume: 35, Issue:1 Topics: Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Exanthema; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Retrospective Studies	2005
Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta tropica, 2005, Volume: 94, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Brazil; Child; DNA, Protozoan; Female; Fluorescent Antibody Technique, Indirect; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Skin Tests	2005
Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis. Clinical and experimental dermatology, 2005, Volume: 30, Issue:3 Topics: Adolescent; Adult; Antioxidants; Antiprotozoal Agents; Child; Child, Preschool; Female; Glutathione Peroxidase; Humans; Leishmaniasis, Cutaneous; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase	2005
[Slowly progressing skin ulcers following a stay in Costa Rica]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:4 Topics: Adult; Animals; Antiprotozoal Agents; Costa Rica; Disease Progression; DNA, Protozoan; Facial Dermatoses; Hand Dermatoses; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; RNA, Protozoan; RNA, Ribosomal; Skin Ulcer; Spain; Travel	2005
Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2005, Volume: 72, Issue:4 Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2005
Symmetrical cutaneous leishmaniasis. Acta dermato-venereologica, 2005, Volume: 85, Issue:3 Topics: Adult; Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Extremities; Female; Humans; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2005
[The cutaneous leishmaniasis of the face in Gafsa area, Tunisia]. Bulletin de la Societe de pathologie exotique (1990), 2005, Volume: 98, Issue:5 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Incidence; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Necrosis; Nose Diseases; Organometallic Compounds; Prospective Studies; Skin Ulcer; Tunisia	2005
Psoriasiform cutaneous leishmaniasis. International journal of dermatology, 2006, Volume: 45, Issue:2 Topics: Antiprotozoal Agents; Diagnosis, Differential; Elbow; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Psoriasis	2006
Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes. The Journal of infection, 2006, Volume: 53, Issue:4 Topics: Adolescent; Antimony; Antiprotozoal Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Knee; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2006
Cutaneous lupoid leishmaniasis: a case report. Cutis, 2006, Volume: 77, Issue:1 Topics: Aged; Antiprotozoal Agents; Diagnosis, Differential; Face; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2006
[Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis]. Medecine et maladies infectieuses, 2006, Volume: 36, Issue:4 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Disease Susceptibility; Drug Eruptions; Facial Dermatoses; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Assessment; Sporotrichosis; Staphylococcal Skin Infections; Superinfection	2006
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. The Journal of infectious diseases, 2006, May-15, Volume: 193, Issue:10 Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Resistance; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Failure; U937 Cells	2006
Scar leishmaniasis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2006, Volume: 16, Issue:4 Topics: Adult; Animals; Cicatrix; Follow-Up Studies; Humans; Injections, Intramuscular; Leg Ulcer; Leishmaniasis, Cutaneous; Leprosy, Tuberculoid; Male; Meglumine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Wound Healing	2006
Atypical cutaneous leishmaniasis resembling eczema on the foot. Dermatology online journal, 2006, Mar-30, Volume: 12, Issue:3 Topics: Adult; Anti-Bacterial Agents; Diagnosis, Differential; Diagnostic Errors; Eczema; Foot; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Steroids	2006
Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. International journal of STD & AIDS, 2006, Volume: 17, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Diagnosis, Differential; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2006
Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:6 Topics: Adolescent; Antiprotozoal Agents; Child; Combined Modality Therapy; Cryotherapy; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin	2006
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy. The American journal of tropical medicine and hygiene, 2006, Volume: 75, Issue:2 Topics: Adult; Animals; Anti-Infective Agents; Antimony; Antiprotozoal Agents; Cartilage; Ciprofloxacin; Ear, External; Humans; Immunocompetence; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pseudomonas Infections; Rifampin	2006
The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis. International journal of dermatology, 2006, Volume: 45, Issue:8 Topics: Adolescent; Adult; Amebicides; Child; Child, Preschool; Chronic Disease; Combined Modality Therapy; Cryotherapy; Drug Therapy, Combination; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin	2006
Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia. Annals of tropical medicine and parasitology, 2006, Volume: 100, Issue:7 Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bolivia; Drugs, Generic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2006
Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model. The Journal of parasitology, 2005, Volume: 91, Issue:4 Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Immunity, Cellular; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2005
Childhood cutaneous leishmaniasis: report of 117 cases from Iran. The Korean journal of parasitology, 2006, Volume: 44, Issue:4 Topics: Adolescent; Animals; Antiprotozoal Agents; Child; Endemic Diseases; Female; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence	2006
Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate. The Journal of infectious diseases, 2007, Feb-15, Volume: 195, Issue:4 Topics: Adult; Antimony; Area Under Curve; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds; Plasma	2007
Leishmania (Viannia) braziliensis infection in two Colombian dogs: a note on infectivity for sand flies and response to treatment. Biomedica : revista del Instituto Nacional de Salud, 2006, Volume: 26 Suppl 1 Topics: Animals; Antiprotozoal Agents; Colombia; Dog Diseases; Dogs; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae	2006
A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate. The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6 Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Cytokines; Drug Therapy, Combination; Immunoglobulin G; Immunologic Factors; Immunotherapy; Interferon-gamma; Interleukin-10; Interleukin-4; Leishmania mexicana; Leishmaniasis, Cutaneous; Lipids; Mannans; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Organometallic Compounds; Polysaccharides	2007
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. The Journal of infectious diseases, 2007, Jun-15, Volume: 195, Issue:12 Topics: Animals; Antimony; Antiprotozoal Agents; Geography; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Species Specificity; Treatment Failure	2007
Recurrent cutaneous leishmaniasis presenting as sporotrichoid abscesses: a rare presentation near Afghanistan border. Dermatology online journal, 2007, May-01, Volume: 13, Issue:2 Topics: Abscess; Adult; Afghanistan; Animals; Diagnosis, Differential; Follow-Up Studies; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Rare Diseases; Recurrence; Severity of Illness Index; Sporotrichosis; Treatment Outcome; Upper Extremity	2007
Possible cardioprotective effect of angiotensin-converting enzyme inhibitors during treatment of American tegumentary leishmaniasis with meglumine antimoniate. Acta tropica, 2007, Volume: 102, Issue:2 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiprotozoal Agents; Cardiotonic Agents; Cardiovascular Diseases; Drug Interactions; Electrocardiography; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Multivariate Analysis; Organometallic Compounds; Retrospective Studies	2007
Disseminated cutaneous leishmaniasis: a patient with 749 lesions. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2006, Volume: 10, Issue:3 Topics: Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2006
An HIV-positive man with tattoo induration. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing	2007
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitology research, 2007, Volume: 101, Issue:5 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine	2007
Dry type leishmanial lymphadenitis presented as two large parotid and cervical masses. International journal of dermatology, 2007, Volume: 46, Issue:7 Topics: Animals; Antiprotozoal Agents; Female; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Lymphadenitis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin	2007
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis. The Journal of parasitology, 2007, Volume: 93, Issue:3 Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Outcome	2007
Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. International journal of dermatology, 2007, Volume: 46, Issue:8 Topics: Adolescent; Adult; Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Face; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	2007
Case report: Leishmaniasis of the upper lip. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 104, Issue:5 Topics: Aged; Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis, Cutaneous; Lip; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2007
[Clinical and histological study of lupoid cutaneous leishmaniasis (16 cases)]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 1 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Biopsy; Child; Disease Progression; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Skin; Time Factors; Treatment Outcome	2007
Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis. Journal of ethnopharmacology, 2008, Jan-17, Volume: 115, Issue:2 Topics: Administration, Oral; Animals; Antiprotozoal Agents; Chenopodium ambrosioides; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Lymph Nodes; Male; Medicine, Traditional; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C3H; Nitric Oxide; Organometallic Compounds; Plant Extracts; Plant Leaves	2008
Mutilating lupoid leishmaniasis: twelve years to make the diagnosis! Dermatology (Basel, Switzerland), 2008, Volume: 216, Issue:2 Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Biopsy; Chronic Disease; Diagnosis, Differential; Follow-Up Studies; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission Induction; Skin; Time Factors	2008
A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant. The American journal of tropical medicine and hygiene, 2008, Volume: 78, Issue:3 Topics: Aged; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2008
[Sporotrichoid cutaneous leishmaniasis in Tunisia: a clinical and histological study]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:1 Topics: Adult; Aged; Anti-Infective Agents; Antiprotozoal Agents; Female; Histiocytes; Humans; Leg Dermatoses; Leishmaniasis, Cutaneous; Lymphocytes; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Sporotrichosis; Tunisia	2008
[Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:4 Topics: Aged; Antiprotozoal Agents; Fatal Outcome; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2008
Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS). International journal of dermatology, 1995, Volume: 34, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antineoplastic Agents; Antiprotozoal Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Rectal Diseases	1995
Thermotherapy v. antimonials: what happens after the healing of cutaneous leishmaniasis lesions? Annals of tropical medicine and parasitology, 1993, Volume: 87, Issue:1 Topics: Animals; Antiprotozoal Agents; Disease Susceptibility; Female; Hyperthermia, Induced; Immunologic Memory; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds; Recurrence	1993
Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome. International journal of dermatology, 1996, Volume: 35, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV Antibodies; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1996
Disseminated American cutaneous leishmaniasis. International journal of dermatology, 1996, Volume: 35, Issue:8 Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Azure Stains; Biopsy; Child; Cricetinae; Culture Media; Cytodiagnosis; Drug Administration Schedule; Drug Resistance; Female; Histiocytes; Humans; Injections, Intradermal; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin Tests; Skin Ulcer; Venezuela	1996
In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11 Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Female; Injections, Subcutaneous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Plant Extracts; Plants, Medicinal	1996
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Experimental parasitology, 1996, Volume: 84, Issue:2 Topics: Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Female; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; T-Lymphocytes	1996
Old-world leishmaniasis of the auricle. Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044 Topics: Adult; Antimony; Antiprotozoal Agents; Ear Diseases; Ear, External; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1997
[Postkala-azar dermal leishmaniasis]. Anales espanoles de pediatria, 1997, Volume: 46, Issue:1 Topics: Animals; Antiprotozoal Agents; Child; Humans; Leishmania donovani; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1997
Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission. International journal of dermatology, 1997, Volume: 36, Issue:6 Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Brazil; Costs and Cost Analysis; Female; Follow-Up Studies; Humans; Injections, Intralesional; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Recurrence; Remission Induction; Skin Ulcer; Treatment Outcome; Wound Healing	1997
Cutaneous leishmaniasis in the Peruvian Andes: factors associated with variability in clinical symptoms, response to treatment, and parasite isolation rate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antiprotozoal Agents; Arm; Child; Disease Transmission, Infectious; Female; Head; Host-Parasite Interactions; Humans; Immunity, Active; Insect Control; Leg; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Occupational Diseases; Organometallic Compounds; Peru; Psychodidae	1997
Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis. Journal of clinical microbiology, 1997, Volume: 35, Issue:12 Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Blotting, Western; Colombia; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Molecular Weight; Organometallic Compounds; Sensitivity and Specificity	1997
Accidental Leishmania mexicana infection in an immunosuppressed laboratory technician. Tropical medicine & international health : TM & IH, 1997, Volume: 2, Issue:12 Topics: Adult; Animals; Female; Humans; Immunosuppression Therapy; Laboratory Infection; Leishmania mexicana; Leishmaniasis, Cutaneous; Lupus Erythematosus, Systemic; Medical Laboratory Personnel; Meglumine; Polymerase Chain Reaction	1997
T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite immunology, 1998, Volume: 20, Issue:1 Topics: Adult; Animals; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Cell Division; Female; Humans; Interferon-gamma; Leishmania; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines; Species Specificity; T-Lymphocytes	1998
Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate. The British journal of dermatology, 1998, Volume: 138, Issue:2 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1998
Effects of antimonial therapy on serum zinc, copper and iron concentrations in patients with cutaneous Leishmaniasis in Turkey. Journal of the Egyptian Society of Parasitology, 1998, Volume: 28, Issue:1 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Copper; Humans; Iron; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trace Elements; Turkey; Zinc	1998
[Cervical cutaneous leishmaniasis]. Acta otorrinolaringologica espanola, 1998, Volume: 49, Issue:3 Topics: Aged; Animals; Female; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Neck	1998
Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. The American journal of tropical medicine and hygiene, 1998, Volume: 58, Issue:6 Topics: Adult; Animals; Biopsy; Cicatrix; Female; Follow-Up Studies; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine	1998
Follicular mucinosis associated with cutaneous leishmaniasis. Acta dermato-venereologica, 1998, Volume: 78, Issue:4 Topics: Antiprotozoal Agents; Biopsy, Needle; Disease-Free Survival; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Mucinosis, Follicular; Organometallic Compounds	1998
South American cutaneous leishmaniasis: report of ten cases in Israeli travelers. Journal of the European Academy of Dermatology and Venereology : JEADV, 1998, Volume: 11, Issue:1 Topics: Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Headache; Humans; Israel; Leg Ulcer; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Liver Function Tests; Male; Meglumine; Meglumine Antimoniate; Muscle Weakness; Muscular Diseases; Organometallic Compounds; Pain; Retrospective Studies; Skin; South America; Travel; Weight Loss	1998
Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. International journal of dermatology, 1998, Volume: 37, Issue:11 Topics: Adult; Animals; Antiprotozoal Agents; Biopsy; DNA, Protozoan; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin	1998
[Efficacy of intralesional treatment with antimonials in four cases of cutaneous leishmaniasis]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17, Issue:2 Topics: Aged; Antimony; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Middle Aged	1999
Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment. The Journal of parasitology, 1999, Volume: 85, Issue:2 Topics: Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1999
Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1999, Volume: 32, Issue:3 Topics: Adult; Aged; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Cutaneous; Long QT Syndrome; Meglumine; Middle Aged; Time Factors	1999
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:2 Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzethonium; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Infusions, Parenteral; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Wound Healing	1999
PCR follow-up examination after treatment of canine leishmaniosis (CaL). The Tokai journal of experimental and clinical medicine, 1998, Volume: 23, Issue:6 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Species Specificity	1998
Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients. Parasite immunology, 2000, Volume: 22, Issue:2 Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; BCG Vaccine; Cell Division; Combined Modality Therapy; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-5; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Protozoan Vaccines; T-Lymphocytes, Helper-Inducer; Th1 Cells; Tuberculin	2000
Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:6 Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mexico; Middle Aged; Organometallic Compounds; Treatment Outcome	1999
American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment. Bulletin of the World Health Organization, 2000, Volume: 78, Issue:8 Topics: Adolescent; Adult; Age Distribution; Analysis of Variance; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Cohort Studies; Evaluation Studies as Topic; Female; Humans; Incidence; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Sensitivity and Specificity; Sex Distribution; Skin Tests	2000
Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice. Scandinavian journal of immunology, 2000, Volume: 52, Issue:5 Topics: Adjuvants, Immunologic; Animals; Antiprotozoal Agents; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Garlic; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phytotherapy; Plants, Medicinal; Th1 Cells; Th2 Cells	2000
A double-blind randomized clinical trial of a topical herbal extract (Z-he) vs. systemic meglumine antimonate. International journal of dermatology, 2000, Volume: 39, Issue:11 Topics: Administration, Topical; Antiprotozoal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Plant Extracts; Randomized Controlled Trials as Topic; Treatment Outcome	2000
[Epidemics of cutaneous leishmaniasis in military personnel working in French Guiana]. Medecine tropicale : revue du Corps de sante colonial, 2000, Volume: 60, Issue:3 Topics: Antiprotozoal Agents; Bedding and Linens; Clothing; French Guiana; Humans; Insect Repellents; Insecticides; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pentamidine; Recurrence; Skin; Trees	2000
Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Memorias do Instituto Oswaldo Cruz, 2001, Volume: 96, Issue:1 Topics: Adult; Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; Cytokines; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines	2001
[Effect of intralesional treatment with emetine hydrochloride on Leishmania (Viannia) braziliensis in hamsters]. Investigacion clinica, 2001, Volume: 42, Issue:1 Topics: Animals; Antiprotozoal Agents; Cicatrix; Cricetinae; Cytoplasm; Disease Reservoirs; Drug Evaluation, Preclinical; Emetine; Immunoenzyme Techniques; Injections, Intralesional; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Microscopy, Electron; Organometallic Compounds; Vacuoles	2001
[Infiltrated cutaneous leishmaniasis and sporotrichosis caused by Leishmania major. First Senegalese case]. Bulletin de la Societe de pathologie exotique (1990), 2001, Volume: 94, Issue:1 Topics: Adult; Animals; Diagnosis, Differential; Female; Humans; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Senegal; Sporotrichosis	2001
[A Pediatric case of lupoid leishmaniasis diagnosed by PCR]. Minerva pediatrica, 2001, Volume: 53, Issue:1 Topics: Administration, Oral; Animals; Antifungal Agents; Antimony; Antiprotozoal Agents; Child; Diagnosis, Differential; DNA, Protozoan; Drug Therapy, Combination; Follow-Up Studies; Humans; Itraconazole; Leishmania infantum; Leishmaniasis, Cutaneous; Lupus Vulgaris; Male; Meglumine; Polymerase Chain Reaction; Time Factors	2001
[N-methyl glucamine antimoniate or Glucantime]. Medecine tropicale : revue du Corps de sante colonial, 2000, Volume: 60, Issue:4 Topics: Antiprotozoal Agents; Drug Interactions; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Selection; Treatment Outcome	2000
Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. The American journal of tropical medicine and hygiene, 2001, Volume: 65, Issue:5 Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Child; Female; Follow-Up Studies; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prognosis	2001
The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador. Revista panamericana de salud publica = Pan American journal of public health, 2001, Volume: 10, Issue:6 Topics: Adolescent; Adult; Antiprotozoal Agents; Data Interpretation, Statistical; Ecuador; Female; Health Knowledge, Attitudes, Practice; Humans; Leishmaniasis, Cutaneous; Male; Medicine, Traditional; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rural Population; Socioeconomic Factors	2001
PCR detection of specific Leishmania-DNA in patients with periodontal disease. Pathologica, 2002, Volume: 94, Issue:1 Topics: Adult; Animals; Antiprotozoal Agents; Chronic Disease; DNA, Protozoan; Female; Gingiva; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Monocytes; Organometallic Compounds; Periodontitis; Polymerase Chain Reaction; Radiography; Venezuela	2002
An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region. Parasite (Paris, France), 2002, Volume: 9, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Disease Outbreaks; Female; Humans; Insect Vectors; Isoenzymes; Leishmania; Leishmaniasis, Cutaneous; Male; Mefloquine; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Protozoan Proteins; Psychodidae; Trees	2002
[Cutaneous leishmaniasis of the lid]. Journal francais d'ophtalmologie, 2002, Volume: 25, Issue:5 Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Eyelid Diseases; Female; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2002
American cutaneous leishmaniasis as a rare imported disease in Europe: a case report favourably treated with antimonial derivatives. European journal of epidemiology, 2001, Volume: 17, Issue:8 Topics: Adolescent; Antiprotozoal Agents; Brazil; Diagnosis, Differential; Humans; Italy; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Travel	2001
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ), 1992, Volume: 43, Issue:4 Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Naphthoquinones; Organometallic Compounds; Plant Extracts	1992
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. The American journal of tropical medicine and hygiene, 1992, Volume: 47, Issue:1 Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992
Visceral and cutaneous leishmaniasis in an European paediatric population. Acta clinica Belgica, 1992, Volume: 47, Issue:4 Topics: Animals; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine	1992
Oriental sore: a case report. Oral surgery, oral medicine, and oral pathology, 1992, Volume: 73, Issue:1 Topics: Adult; Antiprotozoal Agents; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Lip Diseases; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992